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ABSTRACT 
 
The development of well-defined polymeric nanoparticles (NPs) as delivery 
carriers for antimicrobials targeting human infectious diseases requires rational design of 
the polymer template, an efficient synthetic approach and fundamental understanding of 
the developed NPs, e.g., drug loading/release, particle stability, and other characteristics.   
In order to develop potentially fully biodegradable, biocompatible polymeric NPs 
with the capability to deliver silver-based antimicrobials, a series of anionic degradable 
NPs (dNPs) were prepared from block copolymers having polyphosphoester (PPE) and 
poly(L-lactide) block segments, designed specifically for silver loading into the 
hydrophilic shell and/or the hydrophobic core.  With the use of three different types of 
silver-based antimicrobials – silver acetate (AgOAc) or one of two silver carbene 
complexes (SCCs), comparative studies of the selection of proper dNP templates for 
silver-loading and release were undertaken.  Then, the comprehensive degradation 
studies, including evaluation of hydrolytic or enzymatic degradability and identification 
of the degradation products, were performed for the fundamental understanding of the 
developed dNPs as potential delivery carriers for silver-based antimicrobials.  Finally, in 
vitro antimicrobial efficacy of the selected Ag-dNPs was compared with that of inherent 
silver compounds against 10 contemporary epidemic strains of Staphylococcus aureus 
and eight uropathogenic strains of Escherichia coli. 
Organocatalyzed ring-opening polymerization (ROP) of ethylene glycol vinyl 
ether-containing cyclic phosphotriester monomer, as an initial fundamental study toward 
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unique degradable, functional polymer materials, was described.  After demonstrating 
the well-controlled homopolymerization of the monomer with predetermined molecular 
weights and narrow molecular weight distributions, the resulting vinyl ether-
functionalized PPE scaffold was conjugated with hydroxyl- or thiol-containing model 
small molecules via three different types of conjugation chemistries – thiol–ene “click” 
reaction, acetalization, or thio–acetalization reaction – revealing efficient routes for 
postpolymerization modifications of functional polymers.  Furthermore, amphiphilic 
diblock copolymers containing the ethylene glycol vinyl ether-functionalized PPE as a 
hydrophobic block segment, also prepared by ROP, afforded well-defined micelles that 
showed a pH-dependent hydrolytic core degradability of both backbone and side chains 
in aqueous solutions.  The degradation products, as identified by mass spectrometry, 
were found to be nontoxic toward two standard cell lines: RAW 264.7 mouse 
macrophages and OVCAR-3 human ovarian adenocarcinoma cells. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
1.1. Background and Motivation 
Serious lung infections, such as pneumonia, tuberculosis and chronic obstructive 
cystic fibrosis (CF)-related bacterial diseases, are increasingly difficult to treat and can 
be life-threatening.  A number of therapeutics and/or diagnostics have been exploited for 
treatment and/or diagnosis of pulmonary infections.  However, poor solubility of some 
antimicrobial agents, unfavorable pharmacokinetics, lack of selectivity for penetration 
into diseased tissues, advent of bacteria with multiple drug resistances
1,2
 and, as a result, 
administration of higher-intensity antibiotic regimens pose significant obstacles to 
optimizing therapeutics.
3
  A promising approach to alleviate these critical barriers in 
traditional treatment is the development of engineered nanoparticles (NPs) – i.e. particles 
in the size range 1–1000 nm – as alternative delivery carriers for a wide range of 
therapeutics, including drugs, antibodies, proteins, nucleic acids, and various diagnostic 
agents.
2,4
  A wide range of types of NPs, such as dendrimers, fullerenes, metallic NPs, 
etc., have been loaded with therapeutic agents and/or imaging probes to improve 
pharmacokinetics and biodistribution profiles of their small-molecule cargo, aiming to 
achieve maximum delivery to diseased tissues while reducing the exposure of healthy 
tissues to the introduced materials.
5-8
  Among the diverse selection of nanocarriers, NPs 
constructed from polymeric backbone-structured building blocks offer precise control 
over their architectures, surface characteristics, and supramolecular assembly.
9,10
  Direct 
 2 
 
delivery of polymeric NPs, loaded with appropriate antimicrobials and equipped with 
“smart” features to overcome various mucosal and cellular barriers, is a promising 
approach to optimally localize treatment to the site of infection with minimal systemic 
adverse effects or toxicity from the applied therapeutic agents. 
1.2. Organocatalyzed Ring-Opening Polymerization 
Synthesis of polymers with predictable molecular weight, high end group fidelity 
and low polydispersity has been a tremendous interest in the last decades.  
Conventionally, ring-opening polymerization (ROP) of cyclic esters were mediated by 
metals such as Al or Sn.
55, 56
  However, these metal catalysts typically follow 
unavoidable concerns in the field of electronic and medical applications as the residual 
metals may affect the quality of the product.  To address these issues, cyclic carbenes 
and bifunctional thiourea amines (1, 2) were employed as effective catalysts for cyclic 
esters, but the prolonged reaction time was a hurdle to surmount (Figure 1.1.).
57, 58
  
Recently, there has been a considerable interest in bicyclic guanidine-based 
organocatalysts, e.g. 1,5,7-triazabicyclo-[4,4,0]dec-5-ene (3, TBD) (pKa = 26.0) and 7-
methyl-1,5,7-triazabicyclo-[4,4,0]dec-5-ene (4, MTBD) (pKa = 25.3) or in structurally 
similar amine bases, e.g. 1,8-diazabicyclo[5,4,0]unde-7-ene (5, DBU) (pKa = 24.3), for 
their controlled high activity for solution-phase ROP of cyclic esters.
59, 60 
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Figure 1.1.  Organocatalysts used for ROP cyclic esters. 
 
Degradable polymers such as aliphatic polyesters, polycarbonates, and 
polyphosphoesters have been of interest as materials for biomedical applications due to 
their low toxicity, biocompatibility and degradability.
14-16
  Also, the synthetic versatility 
of cyclic esters has brought even more attention in the preparation of functional 
degradable polymers by ROP.  As for the precise control over the physical properties 
and the applications of biologically-active molecules to the degradable polymer 
structures, however, postpolymerization modification provides a more facile means to 
introduce a desired functionality since not all functional groups may be compatible with 
the ROP process or the additional functionalities may limit the polymerization 
efficiency.
69
  As a result, the postpolymerization processing of the polymer backbone or 
side chains is inevitable, and it has been studied extensively with efficient and versatile 
chemistries.
70-72 
1.3. Polymer-Based Nanomedicine for Treatment of Lung Infections 
 A myriad of antimicrobials have been developed for the treatment of lung 
infectious diseases,
11
 yet several key barriers remain.  These barriers include reduced 
patient compliance to the prescribed regimens in the long-term therapy, emergence of 
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multi-drug resistant bacteria, drug toxicity from multiple daily doses, etc., representing a 
need for optimized design of an efficient delivery platform for the lungs.
12
  To address 
these limits in the treatment of lung infections, advances in nanomedicine hold a great 
promise for the delivery of therapeutic agents.
13-16
  In general, incorporation of 
therapeutics into polymeric NPs offers precise control over particle composition, size, 
and structure contributing to the improved pharmacokinetics, enhanced aqueous 
solubility of insoluble hydrophobic drugs, stabilization of therapeutic agents against 
possible hydrolytic and/or enzymatic degradation, mediation of sustained and/or stimuli-
responsive release of the payloads, and mimicking natural nanosystems, e.g. viruses, 
lipoproteins and proteins, for cell-specific targeted delivery with increased 
bioavailability, etc.
2,3,9,10
  Specific to drug and gene delivery, several reports have 
highlighted the prolonged retention time and alleviated mucociliary clearance, leading to 
a reduction of the required dose, by employing polymeric nano-carriers in the treatment 
of respiratory diseases.
17
  Furthermore, the feasibility of incorporation of surface-
decorating moieties (such as selective cell-targeting peptides) onto polymeric NPs 
represents a route toward enhancement of the ratio of drug concentrations at diseased 
tissue to normal tissue with minimal systemic adverse effects. 
1.4. Challenges in the Treatment of Lung Infections Using Polymeric 
Nanoparticles as Delivery Carriers 
 Some of the major challenges associated with pulmonary NP delivery include 
mucociliary clearance, steric hindrance, adhesiveness, and enzymatic activity of the 
mucus gel or sputum, and uptake by alveolar macrophages, etc.
18-21
  For instance, 
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delivery of drugs or nucleic acids loaded within nanocarriers into the airways for 
treatment of CF-related bacterial infections is inefficient, ascribed mostly to the presence 
of sputum having a bulk viscosity ca. 10
5
 times greater than water.
19,22,23
  As a delivery 
carrier, destabilization of NPs can be a direct consequence of drug leakage, disassembly 
and/or biodegradation of the particles, detachment of surface-decorating moieties, 
opsonization, etc.
9,13
  Even though the drug encapsulation-strategy into NPs has shown 
the superiority in targeting and sustained release, as compared to free drugs, it still 
suffers from rapid clearance by the mononuclear phagocytic system (MPS) upon 
deposition onto the lungs.
24
  Furthermore, exhalation, effects of degradation products, 
cytotoxicity, immunogenicity, etc. should be also accounted for in the design and 
administration of polymeric NPs for treatment of respiratory diseases.
25
 
1.5. Scope of this Dissertation 
This dissertation is focused on the development of highly well-defined polymeric 
NPs demonstrating unique performance toward the effective treatment of infectious 
diseases, the combination of state-of-the-art polymerization chemistry, e.g. anionic ROP, 
postpolymerization, and supramolecular assembly processes. 
In Chapter II, a diblock copolymer, polyphosphoester-block-poly(L-lactide) 
(PPE-b-PLLA), which has potential for being fully degradable and biocompatible, was 
synthesized by one-pot sequential ROPs (Figure 1.2.).  Subsequently, photoinduced 
thiol-yne “click” reactions with small-molecule thiols bearing either carboxylic acid or 
amino groups afforded amphiphilic diblock copolymers.  Finally, direct dissolution of 
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the two different types of amphiphilic diblock copolymers in aqueous solutions yielded 
well-defined spherical micelles. 
 
 
Figure 1.2.  Representative research description in Chapter II. 
 
In Chapter III, a series of anionic dNPs from block copolymers having PPE and 
PLLA block segments, designed specifically for silver loading into the hydrophilic shell 
and/or the hydrophobic core, were prepared (Figure 1.3.).  With the use of three different 
types of silver-based antimicrobials – silver acetate (AgOAc) or one of two silver 
carbene complexes (SCCs), comparative studies of the selection of proper dNP 
templates for silver-loading and release were undertaken.  Then, the comprehensive 
degradation studies, including evaluation of hydrolytic or enzymatic degradability and 
identification of the degradation products, were performed for the fundamental 
understanding of the developed dNPs as potential delivery carriers for silver-based 
antimicrobials.  Finally, in vitro antimicrobial efficacy of the selected Ag-dNPs was 
compared with that of inherent silver compounds against 10 contemporary epidemic 
strains of Staphylococcus aureus and eight uropathogenic strains of Escherichia coli. 
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Figure 1.3.  Representative research description in Chapter III. 
 
In Chapter IV, PPE with vinyl ether side chain functionality was developed as a 
versatile template for postpolymerization modifications, and its degradability and 
biocompatibility were evaluated (Figure 1.4.).  This vinyl ether-functionalized PPE 
scaffold was coupled with hydroxyl- or thiol-containing model small molecules via three 
different types of conjugation chemistries – thiol–ene “click” reaction, acetalization, or 
thio–acetalization reaction – to afford modified polymers that accommodated either 
stable thio-ether or hydrolytically-labile acetal or thio-acetal linkages.  Amphiphilic 
diblock copolymers of poly(ethylene glycol) and PEVEP formed well-defined micelles 
with a narrow and monomodal size distribution in water.  The stability of the micelles 
and the hydrolytic degradability of the backbone and side chains of the PEVEP block 
segment were evaluated, and the cytotoxicity o the parent micelles and their degradation 
products were assessed in vitro. 
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Figure 1.4.  Representative research description in Chapter IV.  
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CHAPTER II  
CONSTRUCTION OF A REACTIVE DIBLOCK COPOLYMER, 
POLYPHOSPHOESTER-BLOCK-POLY(L-LACTIDE), AS A VERSATILE 
FRAMEWORK FOR FUNCTIONAL MATERIALS THAT ARE CAPABLE OF FULL 
DEGRADATION AND NANOSCOPIC ASSEMBLY FORMATION*
1
 
 
 
2.1. Introduction 
The use of hydrocarbon backbone-based polymers in the development of 
polymeric nanoconstructs is a well-established concept in nanomedicine, but toxicity, 
immunogenicity, and other side effects from long-time accumulation in the human body 
are often an inevitable bottleneck in the field of therapeutics, imaging, diagnostics, and 
drug delivery.
26
  To overcome this fatal drawback, hydrolytically-degradable polymers 
such as polyesters and polycarbonates have been studied as potential biomaterials owing 
to their low toxicity, biocompatibility, and degradability.
27,28
 
In spite of their great promises in nanomedicine, elaborate synthetic approaches 
due to difficulties experienced in controlling polymerizations, challenges in the 
introduction of functionalities, incompatibilities of desired functionalities with 
polymerization methods, and tedious workup processes often present challenges toward 
                                                 
*
Part of this work is reprinted with permission from “Construction of a Reactive Diblock 
Copolymer, Polyphosphoester-block-Poly(L-lactide), as a Versatile Framework for 
Functional Materials That Are Capable of Full Degradation and Nanoscopic Assembly 
Formation” by Lim, Y. H., Heo, G. S., Cho, S., and Wooley, K. L., 2013, ACS Macro 
Lett., 2(9), 785–789.  Copyright [2013] by the American Chemical Society. 
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developing well-defined, functional degradable biomaterials.
29-31
  A broad range of 
organocatalysts have been studied extensively in ring-opening polymerizations 
(ROPs),
32-35
 which offer controllability while avoiding potential purification issues and 
biological complications of the traditional metal-based catalyst systems.
36,37
  Although 
there are exceptions,
38
 the introduction of side-chain functionalities into the cyclic 
monomers commonly involves multistep reactions.  In contrast, cyclic phospholanes 
offer a straightforward, single-step installation of reactive functionalities that are 
compatible with the ROP conditions and also provide opportunities for diverse 
postpolymerization modification reactions, including “click”-type reactions.39-43  
Introducing these “clickable” functionalities onto cyclic monomers is of particular 
interest with respect to the synthetic approach to degradable polymers, as this sequence 
of chemistry would not only broaden the synthetic versatility but also enable the 
construction and fabrication of intricate polymeric nanoparticles for pharmaceutical 
applications.
39,40 
  
“Hybrid” polymers can provide a mechanism to accommodate disparate physical, 
chemical, and mechanical advantages from diverse polymer segments.
44-47
  Particularly, 
integrating heterogeneous degradable polymers into one polymeric system is expected to 
enhance the combinatorial effects on the development of versatile polymer frameworks, 
which is often limited in the case of a single-type copolymer backbone system.  Among 
important biomedical degradable polymers, polylactide (PLA)
48-51
 is an interesting 
building block for the construction of functional nanoscopic objects, due to its capability 
for hydrolytic and/or enzymatic degradation and several elegant works on the formation 
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of well-defined polymeric nanostructures with distinctive core–shell morphologies and 
higher-order complexities based on the adaptation of the intrinsic hydrophobicity and 
crystallinity of PLAs within amphiphilic block copolymers.
52-55
  Therefore, we have 
combined our recent exploration into a rapid and facile construction of nanostructures 
derived from a biomimetic polyphosphoester
56-60
-based block copolymer system
39,40
 
with PLA. 
The first attempt to prepare a diblock copolymer of L-lactide (LLA) and 
phospholane, PLLA-b-PPE, was made by Wang et al.;
61
 however, it required demanding 
two-step polymerizations using metal catalyst, Sn(Oct)2, and no functional moieties were 
incorporated into the polymeric system.  In this report, we demonstrate the preparation 
of fully degradable, hybrid, functional diblock copolymers by one-pot sequential ROPs 
of two different kinds of cyclic monomers, phospholane and LLA, using an 
organocatalyst, 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU).  This platform was, 
subsequently, modified by a radical-mediated “click”-type thiol-yne reaction to endow 
charges and functional side-chain moieties to the polyphosphoester (PPE) segment.  The 
obtained functionalized diblock copolymers, in turn, were demonstrated to self-assemble 
into well-defined spherical nanoparticles in aqueous solutions with corresponding 
surface charges, as characterized by transmission electron microscopy (TEM), dynamic 
light scattering (DLS), and zeta potential analyses. 
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2.2. Results and Discussions 
Compared to our previous reports, in which sequential ROPs of two 
phospholanes were conducted at different temperatures on a Schlenk line, the ROPs of 
butynyl phospholane (BYP, 1)
40
 and LLA were performed in a one-pot manner in a 
glovebox, at ambient temperature, and with convenience in the elimination of potential 
introduction of water as a competitive initiator.  In an initial study, homopolymer, 
PBYP, was prepared by employing DBU as the organocatalyst and benzyl alcohol as the 
initiator (Figure 2.1.).  The conversion reached up to 95% with a low polydispersity 
index (PDI ~1.2) within 7 min in dichloromethane (CH2Cl2).  After this initial screening 
reaction, kinetic studies of each sequence of the polymerizations in the glovebox were 
performed. 
 
 
Figure 2.1.  Synthetic route for the preparation of alkyne-functionalized PBYP49-b-
PLLA44, 2, by one pot-sequential ROP, followed by post-polymerization modifications 
via thiol-yne “click”-reactions using either 3-mercaptopropionic acid or 2-
aminoethanethiol to prepare aPPE49-b-PLLA44, 3, and cPPE49-b-PLLA44, 4, respectively, 
and finally, schematic illustration of the assembly of 3 and 4 into spherical micelles by 
direct dissolution in water to afford anionic and cationic micelles, 5 and 6, respectively 
(aPPE = anionic PPE and cPPE = cationic PPE). 
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For the kinetic studies, BYP and benzyl alcohol (molar ratio of 50:1) were mixed 
in CH2Cl2, DBU (molar ratio to initiator of 2:1) was added; and the polymerizations 
were monitored.  After being stirred for a predetermined period of time, an aliquot of the 
reaction mixture was collected, quenched by addition of a solution of benzoic acid in 
CH2Cl2, and then analyzed by 
31
P NMR spectroscopy and GPC (Figure 2.2.).  While the 
conversions were calculated from 
31
P NMR spectroscopy by comparing the integral 
ratios of two distinct peaks of monomer, 1, at 17.34 ppm and homopolymer, PBYP, at – 
1.60 ppm, both the molecular weight and its distribution were determined by GPC.  The 
GPC molecular weight values were of low accuracy because they are based on 
calibration with polystyrene standards; however, we believe that the molecular weight 
distributions are representative of the controlled nature of the polymerizations.  
Polymerization proceeded rapidly, in which the monomer conversion reached to 67% 
within the beginning 2 min.  The maintenance of linearity of Mn vs. monomer conversion 
suggested a living ROP up to 95%.  The PDIs were less than 1.30, and even lower PDI 
values (<1.20) were obtained when the monomer conversion was <95%.  The increased 
PDI at higher monomer conversions could be attributed to adverse transesterification of 
the polyphosphoester backbone.  Kinetic plots of ln([M]0/[M]) vs. time indicated pseudo-
first order kinetics, which are a typical characteristic of ROP.  The degrees of 
polymerization (DP) calculated based on 
31
P NMR spectroscopy-determined monomer 
conversions agreed with those calculated from chain-end analysis by 
1
H NMR 
spectroscopy, that is, by comparisons of the integrals of proton resonances of the benzyl 
group (7.427.30 ppm) of the initiated chain end to those of the PBYP backbone 
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(4.344.22 ppm) or those of the - and β-protons on the substituents (4.224.08 ppm 
and 2.672.56 ppm, respectively).  
 
Figure 2.2.  (a) Kinetic plots of Mn and Mw/Mn vs. monomer conversion in ROP of BYP, 
obtained from GPC analysis.  (b) GPC traces as a function of polymerization time.  (c) 
Pseudo-first-order kinetic plots of ln([M]0/[M]) vs. time, obtained from 
31
P NMR 
spectroscopy data.  Conditions: [BYP] = 5.7 M in CH2Cl2, [BYP]:[BnOH]:[DBU] = 
50:1:2. 
 
PBYP was extended with PLLA via a one-pot sequential polymerization method, 
which provides a facile strategy to prepare diblock copolymers with structural control in 
an atom-efficient and labor-saving approach.  It is noteworthy that the ROP rate of 
phospholanes is strongly dependent on the monomer and organocatalyst 
concentrations.
40
  Therefore, we speculated that manipulations of monomer 
concentration in solution would enable the construction of diblock copolymers, while 
maintaining a high efficiency of ROP of two cyclic monomers sequentially, each using 
DBU.  For this reason, ROP of LLA was conducted after the formation of the PPE block.  
That is, when the concentration of BYP in the initial polymerization mixture was diluted 
from 5.7 to 0.28 M after consumption of 95% of BYP and further to 0.036 M and the 
DBU concentration was reduced from 0.23 to 0.028 M upon the addition of the second 
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monomer solution in CH2Cl2, the rate of BYP polymerization slowed to an 
immeasurable level, as confirmed by 
31
P NMR spectroscopy.  Therefore, addition of 
LLA in CH2Cl2 promoted an extension of the second block while preventing further 
growth of PBYP. 
The kinetic study showed that the chain extension of PLLA was achieved within 
a few minutes with good control (Figure 2.3.).  At 7 min of polymerization of BYP (after 
which a rapid increase in PDI was shown), a solution of LLA in CH2Cl2 was quickly 
added into the reaction mixture.  An aliquot of the reaction solution was collected, 
quenched, and analyzed by 
1
H NMR spectroscopy and GPC.  The conversion of LLA 
had reached 90% with a low PDI (~1.2) after 4 min.  A linearity of Mn vs. monomer 
conversion was observed during polymerization, up to 80% conversion with low PDIs 
(<1.20).  Similar to the polymerization of BYP, the kinetic plots of ln([M]0/[M]) vs. time 
for LLA chain extension showed pseudo-first-order kinetics. 
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Figure 2.3.  (a)  Kinetic plots of ln([M]0/[M]) vs. time, obtained from 
1
H NMR 
spectroscopy data.  (b) GPC traces (DMF as eluent, 1 mL/min) as a function of 
polymerization time, for the chain extension of LLA to PBYP after a solution of LLA in 
CH2Cl2 was added at 7 min of homopolymerization of BYP.  (c) Kinetic plots of Mn and 
Mw/Mn vs. monomer conversion, obtained from GPC analysis, during the chain extension 
of PBYP with PLLA via one-pot sequential ROPs.  Conditions: [LLA] = 0.72 M in 
CH2Cl2, [LLA]:[PBYP] = 50:1. 
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A scaled-up production of 2 was then conducted using the same molar ratios as 
used for the kinetic studies, followed by precipitation in diethyl ether for purification.  
The DP values were determined by 
1
H NMR and 
31
P NMR spectroscopy end-group 
analysis and monomer conversion calculations, respectively.  Furthermore, the integral 
ratios between the peak of the terminal acetylene proton (2.282.09 ppm) within the 
PBYP block and that of the methine or methyl protons on the PLLA block were 
consistent, which was indicative of retention of the alkyne groups.  In addition, one 
distinct 
31
P resonance confirmed the stability of the degradable PPE backbone during the 
ROP of LLA and isolation and characterization of the block copolymer.  GPC analysis 
of the diblock copolymer showed a monomodal peak with PDI of 1.17. 
To afford positive or negative charges along the backbone of one segment of the 
diblock copolymer, in the construction of amphiphilic block copolymers, thiol-yne 
“click” reactions were conducted to couple two different kinds of thiol-containing 
compounds onto the PPE block.  The radical-mediated thiol-yne “click” chemistry is a 
robust and versatile method that tolerates a variety of functional groups in achieving a 
high degree of functionalization on alkyne groups.
62,63
  Herein, this efficient click 
chemistry was applied to achieve double addition of small molecules at each PPE repeat 
unit by coupling two equivalents of thiols onto one alkyne moiety.  This double 
conjugation of molecules onto the hydrophilic segment would maximize the number of 
functionalities as well as the solubility of the amphiphilic diblock copolymers in water.  
To confirm the integrity of the polyphosphoester and poly(L-lactide) backbones under 
the presence of radicals and UV irradiation, a mixture of polymer and 2,2-dimethoxy-2-
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phenylacetophenone (DMPA) as a photo-initiator in dimethyl sulfoxide-d6 (DMSO-d6) 
was irradiated under UV light (365 nm, 6 W) for several hours, as a preliminary control 
reaction.  Both 
1
H and 
31
P NMR spectra demonstrated that all of the functional groups 
and polymer backbones were intact under these conditions.  Accordingly, ten molar 
equivalents of thiols relative to alkynes were employed in the radical reaction to avoid 
possible chain–chain coupling and to ensure a high coupling efficiency.  3-
Mercaptopropionic acid and 2-aminoethanethiol were chosen because of their 
commercial availability and the potential self-assembly into anionic or cationic 
nanoparticles from the resulting negatively or positively charged amphiphilic block 
copolymers, respectively.  
Figure 2.4. shows a comparison of 
1
H and 
31
P NMR spectra of PPE49-b-PLLA44 
before and after thiol-yne “click” reactions.  The approximately complete disappearance 
of the terminal acetylene proton (labeled as g in Figure 2.4.(a)), coincident with the 
emergence of distinguishable diastereotopic methylene protons (labeled as k in Figures 
2(b) and 2(c)) confirmed the conversion of alkynyl groups into the corresponding 1,2-
dithioether functional groups.   
 
 19 
 
 
Figure 2.4.  
1
H- and 
31
P-NMR spectra of 2 (a), and product polymers after thiol-yne 
“Click” reactions, 3 (b) and 4 (c). 
 
The self-assembly behaviors of the two amphiphilic diblock copolymers, 3 and 4, 
were studied by direct dissolution in buffer solution.  3 and 4 were dissolved and stirred 
for 10 min in 3-(N-morpholino)propanesulfonic acid (MOPS) buffer solution (pH 7.4, 
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150 mM) and acetate buffer solution (pH 5.0, 150 mM), respectively, with polymer 
concentrations of 1.0 mg/mL.  The morphologies of the resulting nanoparticles having 
different charges within their hydrophilic shells were characterized by DLS and TEM 
(Figure 2.5.).  DLS results indicated narrow and monomodal size distributions of anionic 
and cationic nanoparticles.  For 5, the number-average hydrodynamic diameter was ca. 
25 nm.  The number-average hydrodynamic diameter of 6 was ca. 16 nm.  Similarly, 
TEM images of 5 and 6 also showed uniform particles with average sizes of 
approximately 18 and 16 nm, respectively. 
 
 
Figure 2.5.  Self-assembly results of anionic micelle 5 (a and b) and cationic micelle 6 (c 
and d) in MOPS buffer at pH 7.4 and acetate buffer at pH 5.0, respectively.  (a) TEM 
image of 5: Dav = 18 ± 3 nm, after counting more than 150 nanoparticles.  (b) DLS 
results of 5: Dh(intensity) = 41 ± 14 nm, Dh(volume) = 31 ± 10 nm, and Dh(number) = 25 ± 6 nm.  
(c) TEM image of 6: Dav = 16 ± 2 nm, after counting more than 150 nanoparticles.  (d) 
DLS results of 6: Dh(intensity) = 125 ± 129 nm, Dh(volume) = 24 ± 15 nm, and Dh(number) = 16 
± 5 nm. 
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The surface charge densities of 5 and 6 in buffer solutions at pH 5.0 and 7.4 were 
measured as zeta potential values (Figure 2.6.).  As predicted, 5 were negatively charged 
with zeta potentials of –16.9 mV at pH 5.0 and –25.5 mV at pH 7.4, and 6 were 
positively charged, showing zeta potential values of +31.4 mV at pH 5.0 and +26.0 mV 
at pH 7.4.  The distinct difference in zeta potential values demonstrated the presence of 
surface charges on the micelles as well as the potential utilization of functionalities for 
further modifications. 
 
 
Figure 2.6.  Zeta potential values of micelles, 5 and 6, in MOPS buffer at pH 7.4 and 
acetate buffer at pH 5.0.  The average values and their standard deviations were made 
from six-time measurements. 
 
2.3. Experimental Section 
2.3.1.  Materials 
Dimethyl sulfoxide (DMSO), 3-Bytyn-1-ol, 3-mercaptopropionic acid, 2-
aminoethanethiol, 2,2-dimethoxy-2-phenylacetophenone (DMPA), diethyl ether and 
benzoic acid were used as received from Sigma-Aldrich Co.  2-chloro-2-oxo-1,3,2-
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dioxaphospholane (COP, 95%) was used as received from Thermo Fisher Scientific Inc.  
Benzyl alcohol and 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU) were purchased from 
Sigma-Aldrich Co. and distilled from calcium hydride prior to use.  L-lactide (98%, Alfa 
Aesar) was purified and dried by azeotropic distillation in toluene three times.  The dried 
L-lactides were stored in an argon-filled glovebox.  Tetrahydrofuran (THF) and 
dichloromethane (CH2Cl2) were dried through columns (J. C. Meyer Solvent Systems, 
Inc.).  Spectra/Pro® membranes (MWCO 1214 kDa, Spectrum Medical Industries, Inc. 
were used for dialysis. 
2.3.2.  Characterization Methods 
1
H, 
13
C, and 
31
P NMR spectra were recorded on Inova 300 MHz spectrometers 
interfaced to a UNIX computer using VnmrJ software.  Chemical shifts were referenced 
to solvent resonance signals. 
The DMF gel permeation chromatography (GPC) was conducted on a Waters 
Chromatography, Inc. (Milford, MA) system equipped with an isocratic pump model 
1515, a differential refractometer model 2414, and a four-column set of 5 µm Guard (50 
x 7.5 mm), Styragel HR 4 5 µm DMF (300 x 7.5 mm), Styragel HR 4E 5 µm DMF (300 
x 7.5 mm), and Styragel HR 2 5 µm DMF (300 x 7.5 mm).  The system was equilibrated 
at 70 °C in pre-filtered DMF containing 0.05 M of LiBr, which served as polymer 
solvent and eluent (flow rate set to 1.00 mL/min).  Polymer solutions were prepared at a 
concentration of ca. 5 mg/mL and an injection volume of 200 µL was used.  Data 
collection and analysis were performed with Empower 2 v. 6.10.01.00 software (Waters, 
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Inc.).  The system was calibrated with polystyrene standards (Polymer Laboratories, 
Amherst, MA) ranging from 615 to 442800 Da. 
Thermogravimetric analysis (TGA) was performed under N2 atmosphere using a 
Mettler-Toledo model TGA/SDTA851e, with a heating rate of 10 °C/min and cooling 
rate of 5 °C/min.  Measurements were analyzed using Mettler-Toledo Star
e
 v. 7.01 
software. 
Glass transition temperatures (Tg) were measured by differentia scanning 
calorimetry (DSC) on a Mettler-Toledo DSC822® (Mettler-Toledo, Inc., Columbus, 
OH), with a heating rate of 10 °C/min.  Measurements were analyzed using Mettler-
Toledo Star
e
 v. 7.01 software.  The Tg was taken as the midpoint of the inflection 
tangent, upon the third heating scan. 
Dynamic light scattering (DLS) measurements were conducted using Delsa Nano 
C (Beckman Coulter, Inc., Fullerton, CA) equipped with a laser diode operating at 658 
nm.  Size measurements were made in nanopure water (n = 1.3329, ƞ = 0.890 cP at 25 ± 
1 °C).  Scattered light was detected at 165° angle and analyzed using a log correlator 
over 70 accumulations for a 3.0 mL sample in a glass sizing cell (4.0 mL capacity).  The 
samples in the glass sizing cell were equilibrated for 30 min before measurements were 
made.  The photomultiplier aperture and the attenuator were automatically adjusted to 
obtain a photon counting rate of ca. 10 kcps.  Calculation of the particle size distribution 
and distribution averages was performed using COTIN particle size distribution analysis 
routines.  The peak averages of histograms from number distributions out of 70 
accumulations were reported as the average diameters of the particles. 
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Transmission electron microscopy (TEM) images were collected on a JEOL 
1200EX operating at 100 kV and micrographs were recorded at calibrated 
magnifications using a SIA-15C CCD camera.  The samples as aqueous solutions (5 µL) 
were deposited onto carbon-coated copper grids.  Excess sample was wicked off using 
filter paper and the grids were allowed to dry in air for 1 min.  Following that, the grids 
were stained with 5 µL of a 2% uranyl acetate aqueous solution.  Excess stain was 
wicked off using filter paper after 20 seconds.  The sample grids were dried under 
vacuum overnight before analysis. 
The zeta potential values of the nanoparticles were determined by Delsa Nano C 
particle analyzer (Beckman Coulter, Fullerton, CA) equipped with a 30 mW dual laser 
diode (658 nm).  The zeta potential of the particles in suspension was obtained by 
measuring the electrophoretic movement of charged particles under an applied electric 
field.  Scattered light was detected at a 30° angle at 25 °C.  The zeta potential was 
measured at five regions in the flow cell and a weighted mean was calculated.  These 
five measurements were used to correct for electroosmotic flow that was induced in the 
cell due to the surface charge of the cell wall.  All determinations were repeated six 
times. 
2.3.3. Synthesis of Butynyl Phospholane (BYP) Monomer 
A solution of 2-chloro-2-oxo-1,3,2-dioxaphospholane (COP, 15.0 g, 105 mmol) 
in 50 mL of anhydrous THF was added dropwise to a stirred solution of 3-butyn-1-ol 
(8.12 g, 116 mmol) and triethylamine (11.7 g, 116 mmol) in 200 mL of anhydrous THF 
at 0 °C. The reaction mixture was allowed to stir for 11 h.  The reaction mixture was 
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filtered and the filtrate was concentrated vial rotary evaporator.  The filtrate was distilled 
under reduced pressure to obtain a faint yellow and viscous liquid (110120 °C, 0.5 
mmHg) with a yield of 52.3%.  IR: 33303170, 30502870, 1474, 1283, 1009, 926, 835, 
756 cm
-1
.  
1
H NMR (CDCl3, ppm): δ 4.504.31 (m, 4H, POCH2CH2OP), 4.21 (dt, J = 
9.3 Hz, J = 6.9 Hz, 2H, POCH2CH2C), 2.59 (ddt, J = 6.9 Hz, 2.7 Hz, 0.3 Hz, 2H, 
POCH2CH2C), 2.02 (t, J = 2.7 Hz, 1H, POCH2CH2CCH).  
13
C NMR (CDCl3, ppm): δ 
79.21, 70.58, 66.38, 66.12, 20.78.  
31
P NMR (CDCl3, ppm): δ 17.34.  +ESI MS: 
calculated [M+H]
+
 for C6H9O4P: 177.0317, found: 177.0311. 
2.3.4. General Procedure of Kinetic Study of Homopolymerization of BYP via ROP 
In a glovebox, a solution of BYP (0.608 g, 3.45 mmol) and benzyl alcohol (7.37 
mg, 0.0682 mmol) in anhydrous CH2Cl2 (0.6 mL) was transferred into a 5 mL shell vial 
with a stir bar.  DBU (20.8 mg, 0.137 mmol) was injected into the mixture solution. 0.05 
mL of samples were extracted at 2, 3, 5, 7, 9 and 10 min and quenched by addition of 
solution of benzoic acid in CH2Cl2.  Conversion of monomer to polymer was calculated 
by 
31
P NMR spectroscopy. 
2.3.5. General Procedure of Kinetic Study of Second-block (PLLA) Polymerization 
via ROP 
In a glovebox, a solution of BYP (0.504 g, 2.86 mmol) and benzyl alcohol (6.14 
mg, 0.0568 mmol) in anhydrous CH2Cl2 (0.5 mL) was transferred into a 20 mL vial with 
a stir bar.  DBU (17.3 mg, 0.114 mmol) was injected into the mixture solution.  After 
stirring for 7 min of polymerization, a solution of LLA (409 mg, 2.86 mmol) in 
anhydrous CH2Cl2 (3.5 mL) was added into the mixture solution.  Then, 0.1 mL of 
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samples were extracted at 0.5, 1, 1.5, 2, 2.5, 3, 3.5, and 4 min and quenched by addition 
of solution of benzoic acid in CH2Cl2.  Conversion of monomer, LLA, to polymer was 
calculated by 
1
H NMR spectroscopy. 
2.3.6. One-pot Sequential Block Copolymerization of BYP and LLA, PBYP49-b-
PLLA44 
In a glovebox, a solution of BYP (3.02 g, 17.2 mmol) and benzyl alcohol (37.0 
mg, 0.340 mmol) in anhydrous CH2Cl2 (3.0 mL) was transferred into a vial with a stir 
bar.  DBU (104 mg, 0.682 mmol) was injected into the mixture solution.  After stirring 
for 7 min, a solution of LLA (2.46 g, 17.0 mmol) in anhydrous CH2Cl2 (21 mL) was 
added into the mixture solution.  After 4 min, the reaction was quenched by addition of 
solution of benzoic acid in CH2Cl2.  The product was precipitated in diethyl ether three 
times and dried overnight in vacuum.  4.9787 g (97.6% yield).  GPC: Mn = 21900 g/mol, 
PDI = 1.17.  IR: 33503150, 30502850, 1757, 1456, 1271, 1211, 1184, 1130, 1074, 
1009, 970, 804 cm
-1
.  
1
H NMR (CD2Cl2, ppm): δ 7.427.30 (m, 5H, aromatic ring), 5.16 
(broad q, J = 7.2 Hz, 100H, ArCH2OP and OCCH(O)CH3), 4.344.22 (b, 196H, 
POCH2CH2O), 4.224.08 (b, 98H, POCH2CH2CCH), 2.672.56 (b, 98H, 
POCH2CH2CCH), 2.28-2.09 (b, 49H, OCH2CH2CCH), 1.55  (broad d, J = 7.2 Hz, 264H, 
CH3CH(O)CO).  
13
C NMR (CD2Cl2, ppm): δ 170.02, 130.07, 129.16, 128.57, 80.28, 
71.00, 69.53, 67.00, 66.27, 21.06, 17.02.  
31
P NMR (CD2Cl2, ppm): δ -1.60.  DSC: (Tg) = 
-33.23 °C.  TGA in N2: 190-290 °C, 40% mass loss; 290370 °C, 42% mass loss; 12% 
mass remaining above 370 °C.   
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2.3.7. Thiol-yne “Click” Reaction of PBYP Block of PBYP49-b-PLLA44 with 3-
Mercaptopropionic Acid 
A solution of block copolymer, PBYP49-b-PLLA44 (149 mg, 0.00990 mmol), 3-
mercaptopropionic acid (524 mg, 4.93 mmol), and 2,2-dimethoxy-2-phenylacetophenone 
(215 mg, 0.840 mmol) in 7.5 mL of dimethyl sulfoxide was irradiated under UV 
irradiation (365 nm, 6 W) for 90 min while stirring.  The reaction mixture was purified 
by precipitated in diethyl ether three times, dialyzed in nanopure water and freeze-dried 
overnight to give a white solid.  (189 mg, 75.1% yield).  IR: 36752760, 27002430, 
1757, 1715, 1452, 1408, 1385, 1184, 1130, 1086, 1016, 982, 802, 754 cm
-1
.  
1
H NMR 
(DMSO, ppm): δ 13.211.9 (b, SCH2CH2C(O)OH), 7.447.26 (m, 5H, aromatic ring),  
5.46 (d, J = 6.9 Hz, 2H, OCH2Ar), 5.20 (broad q, J = 7.2 Hz, 88H, OCCH(O)CH3), 
4.353.80 (b, 294H, POCH2CH2O and POCH2CH2CH), 3.002.80 (b, 196H, 
SCH2CH2COOH), 2.802.62 (b, 245H, SCH2CH2COOH and SCH(CH2)CH2CH2), 
2.602.50 (b, 98H, SCH2CHS), 2.252.05 and 1.851.57 (b, 98H, POCH2CH2CH), 1.46 
(broad d, J = 7.2 Hz, 264H, OCCH(O)CH3).  
13C NMR (DMSO, ppm): δ 173.05, 172.19, 
169.27, 68.72, 66.25, 65.34, 44.05, 42.91, 41.67, 38.19, 37.54, 34.73, 34.18, 33.53, 
29.71, 27.18, 26.09, 25.22, 16.53.  
31P NMR (DMSO, ppm): δ -1.19.  DSC: (Tg) = 6.34 
°C.  TGA in N2: 105190 °C, 13% mass loss; 190280 °C, 40% mass loss; 280350 °C, 
25% mass loss; 22% mass remaining above 350 °C.   
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2.3.8. Thiol-yne “Click” Reaction of PBYP Block of PBYP49-b-PLLA44 with 2-
Aminoethanethiol 
A solution of block copolymer, PBYP49-b-PLLA44 (150 mg, 0.0995 mmol), 2-
aminoethanethiol (0.554 g, 4.88 mmol), and 2,2-Dimethoxy-2-phenylacetophenone (250 
mg, 0.975 mmol) in 7.5 mL of dimethyl sulfoxide was irradiated under UV irradiation 
(365 nm, 6 W) for 90 min.  The reaction mixture was purified by precipitated in diethyl 
ether four times, dialyzed in nanopure water at pH 3 and freeze-dried overnight to give a 
white solid. (220 mg, 83.8% yield).  IR: 36003300, 32502470, 1755, 1604, 1454, 
1250, 1184, 1084, 1013, 806, 754 cm
-1
.  
1H NMR (DMSO, ppm): δ 8.607.95 (b, 
SCH2CH2NH3
+
), 7.467.42 (m, 5H, aromatic ring), 5.46 (d, J = 6.9, 2H, OCH2Ar), 5.20 
(broad q, J = 7.2 Hz, 88H, OCCH(O)CH3), 4.403.85 (b, 294H, POCH2CH2O and 
POCH2CH2CH), 3.453.33 (b, 196H, SCH2CH2NH3
+
), 3.202.75 (b, 343H, 
SCH2CHSCH2CH2NH3
+
), 2.302.15 and 1.901.66 (b, 98H, POCH2CH2CHS), 1.46 
(broad d, J = 7.2 Hz, 264H, OCCH(O)CH3).  
13C NMR (DMSO, ppm): δ 169.21, 164.54, 
68.69, 66.45, 65.16, 41.36, 36.96, 33.91, 33.39, 28.64, 26.79, 16.49.  
31
P NMR (DMSO, 
ppm): δ -1.26.  DSC: (Tg) = -7.49 °C.  TGA in N2: 190350 °C, 74% mass loss; 26% 
mass remaining above 350 °C.   
2.3.9. General Procedure for Self-assembly of Functional Diblock Copolymers 
The functional anionic and cationic diblock copolymers (1.0 mg) were suspended 
into MOPS buffer (150 mM) at pH 7.4 and acetate buffer (150 mM) at pH 5.0.  
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2.4. Conclusions 
In conclusion, a versatile platform for the construction of spherical micelles with 
different surface charges and functionalities based on fully degradable, hybrid diblock 
copolymer, PPE-b-PLLA, was developed.  First, well-defined (PDI <1.2) diblock 
copolymers of alkyne-functional phospholanes and L-lactides were prepared by 
conducting rapid and facile one-pot sequential ROPs using an organocatalyst, DBU.  
The kinetic study of each block polymerization demonstrated an excellent controllability 
during ROP.  Subsequently, photoinitiated, radical-mediated thiol-yne “click” chemistry 
was employed to convert the parental hydrophobic diblock copolymer into amphiphilic 
diblock polymers with different side-chain functionalities.  Finally, the direct dissolution 
of the amphiphilic diblock copolymers in water promoted the formation of well-defined 
spherical nanoparticle assemblies with distinct negative and positive surface charges and 
uniform size distributions, as characterized by TEM, DLS, and zeta potential analyses.  
The fundamental understanding of degradability of these diblock copolymers and the 
application of nanoparticles in nanomedicine are currently under investigations. 
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CHAPTER III  
PREPARATION AND IN VITRO ANTIMICROBIAL ACTIVITY OF SILVER-
BEARING DEGRADABLE POLYMERIC NANOPARTICLES OF 
POLYPHOSPHOESTER-BLOCK-POLY(L-LACTIDE)
*
 
 
 
3.1.  Introduction 
A slate of traditional antimicrobial agents has been employed for treatment of 
infectious diseases over the past decades.  However, current therapeutic challenges 
include the rapid emergence of multidrug-resistant organisms, e.g., Gram-positive 
pathogens, Gram-negative enteric bacteria, and Mycobacterium tuberculosis, and 
suboptimal pharmacokinetics and pharmacodynamics, e.g., poor water solubility or lack 
of desired tissue distribution after systemic delivery.
1,2,64-66
  Available strategies to 
address these barriers are limited, usually requiring administration of more frequent or 
higher doses of available, traditional agents, which in turn promotes end-organ toxicities 
and adverse effects.
3
  Therefore, it is imperative to identify and develop new modalities 
of antimicrobial treatment to circumvent these challenges; current themes include 
                                                 
*
 Part of this work is reprinted with permission from “Preparation and in Vitro  
Antimicrobial Activity of Silver-bearing Nanoparticles of Degradable Diblock 
Copolymer, Polyphosphoester-block-Poly(L-lactide)” by Lim, Y. H., Tiemann, K., Heo, 
G. S., Wagers, P. O., Rezenom, Y. H., Zhang, S., Zhang, F., Youngs, Y. J., Hunstad, D. 
A., and Wooley, K. L., 2015, ACS Nano, 9 (2), 1995–2008.  Copyright [2015] by the 
American Chemical Society. 
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candidate antivirulence therapies that will not engender bacterial resistance, as well as 
targeted delivery of antimicrobials to sites of infection in order to limit systemic effects.   
Silver has been used as an antimicrobial agent since ancient times, due to its 
broad spectrum of activity against bacterial and fungal pathogens and relatively low 
toxicity to human tissues.  Additionally, despite its widespread topical use, e.g., in 
wound dressings and burn ointments, instances of bacterial resistance to the biocidal 
activity of silver are rare.
67-72
  Significant efforts have been made to elucidate the 
antimicrobial activity of silver by employing various silver formulations, e.g., 
polyamidoamine dendrimer-based silver complexes and nanocomposites by Balogh et 
al.;
73
 two-component composites of cationic polymer, poly(4-vinyl-N-hexylpyridinium 
bromide), and silver bromide nanoparticles by Sen et al.;
74
 hybrids of silver 
nanoparticles with polyethylenimine-based hyperbranched polymers by Mecking et al.,
75
 
etc.  
Given the potential of these systems, our group has been developing silver-based 
antimicrobial delivery from two different perspectives: (1) improving the stability of the 
active moiety (silver cation, Ag
+
), within an organometallic complex and (2) optimizing 
delivery of silver compounds to sites of epithelial infection by exploiting various 
nanoparticle templates.  Youngs et al. designed a library of N-heterocyclic silver carbene 
complexes (SCCs), which improved the stability of Ag
+ 
to light and aqueous solution, 
allowed for the direct administration of silver-compounds via nebulization, and 
demonstrated the antimicrobial activity of Ag
+
 against contemporary Gram-positive and 
Gram-negative pathogens.
76-84
  In parallel, Cannon and Youngs et al. demonstrated 
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sustained silver release and potent in vitro and in vivo antimicrobial efficacy of SCC10-
bearing L-tyrosine polyphosphate nanoparticles (LTP NPs) against the cystic fibrosis 
pathogen Pseudomonas aeruginosa.
85
  Meanwhile, benefiting from polymeric backbone-
structured building blocks with precisely controlled architectures, surface characteristics 
and supramolecular assembly,
9,10
 Cannon, Youngs, and Wooley et al. highlighted the 
preparation of smaller particle size and the introduction of functionalities for attachment 
of targeting moieties by utilizing multifunctional shell cross-linked knedel-like 
polymeric nanoparticles (SCK NPs) of poly(acrylic acid)-block-polystyrene (PAA-b-
PS).
86,87
  However, in spite of promising in vitro data and in vivo therapeutic outcomes 
after treatment with SCK NPs bearing silver-based antimicrobials in prior studies, 
translational concerns remained regarding in vivo fate, clearance, accumulation and 
possible toxicity, immunogenicity and other side effects that may be elicited by the 
hydrocarbon backbone-based, nondegradable NPs while in mammalian hosts and 
persistent in the environment.
88
 
To address this limitation, we have developed biocompatible and multifunctional 
polymeric nanoconstructs derived from biodegradable precursors, e.g., 
polyphosphoesters, polycarbonates, polyesters, polypeptides, etc. for potential 
application in biomedical settings.
36,89-93
  We have employed a combination of state-of-
the-art polymerization chemistries, “click”-type postpolymerization chemical 
modification and supramolecular assembly with respect to the construction of complex 
and functional polymeric materials.  This sequential chemical approach allows for 
synthetic versatility and fabrication of intricate polymeric nanoparticles for diverse 
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pharmaceutical applications.
39,94-99
  To capture this combinatorial concept, we recently 
demonstrated the rapid and facile synthesis of amphiphilic diblock copolymers, 
composed of phosphoester backbones and both carboxylate and 1,2-dithioether side 
chain functionalities for interactions with silver.
100
  Micellar assemblies comprised of 
these block copolymers were shown to address the issues of weak silver binding and 
nondegradability, however, they raised alternative concerns in having phosphoric acid 
and ethylene glycol as two of the degradation products.  Therefore, in this current work, 
the hydrophobic portion of the polyphosphoester backbone is replaced by poly(L-
lactide), a well-known and broadly applicable polymer that is derived from the natural 
product lactic acid.  Amphiphilic block copolymers containing phosphoester repeat units 
that carry carboxylate and 1,2-dithioether functionalities along the hydrophilic segment 
and L-lactide repeat units along the hydrophobic segment were prepared by an efficient a 
one-pot sequential ring-opening polymerization followed by thiol-yne “click” 
reactions.
94
  Subsequently, this “hybrid” polymer construct facilitated the formation of 
well-defined polymeric nanostructures with distinctive core-shell morphology and 
capable of high loading capacities for several antimicrobial silver species. 
To develop potentially fully biodegradable, biocompatible polymeric NPs with 
the capability to deliver silver-based antimicrobials, we prepared a series of anionic 
dNPs from block copolymers having polyphosphoester (PPE) and poly(L-lactide) 
(PLLA) block segments, designed specifically for silver loading into the hydrophilic 
shell and/or the hydrophobic core.  With the use of three different types of silver-based 
antimicrobials – silver acetate (AgOAc) or one of two silver carbene complexes (SCCs), 
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comparative studies of the selection of proper dNP templates for silver-loading and 
release were undertaken.  Then, the comprehensive degradation studies, including 
evaluation of hydrolytic or enzymatic degradability and identification of the degradation 
products, were performed for the fundamental understanding of the developed dNPs as 
potential delivery carriers for silver-based antimicrobials.  Finally, in vitro antimicrobial 
efficacy of the selected Ag-dNPs was compared with that of inherent silver compounds 
against 10 contemporary epidemic strains of Staphylococcus aureus and eight 
uropathogenic strains of Escherichia coli. 
3.2.  Results and Discussions 
3.2.1.  Rational Design of Polymer Structure and Compositions 
In designing these polymer constructs as optimized delivery carriers, several 
criteria were considered, i.e., degradability, biocompatibility, and functionality.  Its 
susceptibility to hydrolytic and/or enzymatic degradation and loading of hydrophobic 
drugs make polylactide (PLA) popular as a building block for biomedical degradable 
polymers.
101,102
  However, a lack of chemical functionality and intrinsic hydrophobicity 
limit its use as an intelligent delivery carrier itself.  To overcome this limitation, we 
envisioned that incorporating PPE, well-known to be biodegradable and composed of 
fairly hydrophilic phosphotriester linkages,
56,89,103
 with PLA would compensate the 
limitations inherent to PLA alone, while also diluting the potential side effects of 
phosphoric acid and ethylene glycol degradation products.  Furthermore, the facile 
introduction of pendent side functional groups on the pentavalent phosphorus atom 
would maximize their potential as functional delivery carriers.  For instance, in this 
 35 
 
study, 1,2-dithioether and carboxylic acid side chain moieties would represent sites for 
silver cation loading, with the carboxylic acids also offering opportunities for 
conjugation with tissue-specific targeting peptides or proteins.  Loading of hydrophilic 
and/or hydrophobic silver agents within the developed single particle template would be 
feasible.  In addition, we postulated that nanoparticles with different hydrophilic chain 
lengths, i.e., different dimensions of interaction sites for silver cations, may influence the 
silver-loading capacity of nanoparticles and, consequently, the therapeutic effects of 
silver-loaded nanoparticles against in vitro bacterial strains. 
3.2.2.  Preparation of Functional, Degradable Polymeric Nanoparticles 
For the comparative study, each of three amphiphilic diblock copolymers with 
different hydrophilic PPE chain length, anionic polyphosphoester-block-poly(L-lactide) 
(aPPEn-b-PLLA50, n = 50, 90 or 210), 2, was synthesized by one-pot sequential ring-
opening polymerizations (ROP) of alkyne-functionalized cyclic phosphotriester and L-
lactide followed by thiol-yne “click” reactions to introduce functionalities for interaction 
with Ag
+
 and also to impart hydrophilicity to the PPE block segment (Figure 3.1.).
94
  
Well-defined structures of 1 were confirmed by gel permeation chromatography 
analysis, with monomodal molecular weight distributions having PDI <1.26.  In 
addition, in all three precursor polymers, one distinct 
31
P NMR resonance at ca. –1.0 
ppm revealed the stability of the degradable PPE backbone during the ROPs and the 
work-up process of 2. 
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Figure 3.1.  Synthetic route for the preparation of alkyne-functionalized diblock 
copolymer of phosphoester and L-lactide, PPE-b-PLLA, 1, by one-pot sequential ROP, 
followed by postpolymerization modification via thiol-yne “Click” reaction using 3-
mercaptopropionic acid to prepare anionic amphiphilic diblock copolymer, aPPE-b-
PLLA, 2. 
 
The self-assembly behaviors of the three individual polymers of aPPEn-b-
PLLA50, 2 (n = 50, 90 or 210 for 2a, 2b, or 2c, respectively), were studied by direct 
dissolution in nanopure water (Figure 3.2.).  The dimensions and surface charges of the 
resulting dNPs, 3 (n = 50, 90, or 210 for 3a, 3b, or 3c, respectively), were characterized 
by transmission electron microscopy, dynamic light scattering (DLS), atomic force 
microscopy (AFM) and electrophoretic light scattering, respectively.  While DLS 
analyses of 3a and 3b indicated number-average hydrodynamic diameters (Dh(number)) of 
25 and 34 nm, respectively, with monomodal size distributions (PDI <0.13), 3c featured 
the smallest Dh(number) of 13 nm, with a broad distribution (PDI = 0.40) (Figure 3.3.).  The 
inherently hydrophilic 3c displayed higher critical micelle concentration, ca. 0.5 mg/mL, 
owing to its long hydrophilic chain, compared with ca. 0.2 mg/mL of 3a and ca. 0.3 
mg/mL of 3b.  Meanwhile, as predicted, these three different 3 micellar formulations in 
aqueous solutions indicated negative surface charges, having ζ-potential values of –17 to 
–47 mV at pH 5.0 or 7.4, as measured by electrophoretic light scattering (Table 3.1.).  
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Also, well-defined 3 assemblies were observed by TEM with comparable sizes and size 
distributions as observed by DLS (Figure 3.7.).   
 
 
Figure 3.2.  Schematic illustration of the self-assembly of 2a–2c into anionic micelles, 
3a–3c, by direct dissolution in water followed by silver loading.  Schematic 
representation of silver cation, Ag
+
, (blue ball) from AgOAc and SCC22 or SCC10 
(yellow ball) chelated into the corona or incorporated into the core of 3, Prepared from 2. 
(Note: the placements of the silver species within the dNP framework are proposed 
locations that have not been confirmed experimentally.) 
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Figure 3.3.  Dynamic light scattering histograms.  Average values from 10 
measurements, with standard deviations calculated as the breadth of the distributions.  
Green bars:  Dh(intensity), red bars: Dh(volume) and blue bars: Dh(number).  Top row: (a) naked 
3a, (b) AgOAc-3a, (c) SCC22-3a, and (d) SCC10-3a.  Middle row: (e) naked 3b, (f) 
AgOAc-3b, (g) SCC22-3b, and (h) SCC10-3b.  Bottom row: (i) naked 3c. 
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Table 3.1.  Summary of characterization data from naked nanoparticles of aPPE-b-
PLLA, 3, as measured by TEM, DLS, AFM, and electrophoretic light scattering. 
Type 
of NPs 
TEM 
(nm) 
Dh(intensity) 
(nm) 
Dh(volume) 
(nm) 
Dh(number) 
(nm) 
PDI 
AFM 
(nm) 
ζ-potential 
(mV) 
3a 18 ± 3 41 ± 14 31 ± 10 25 ± 6 0.11 38 ± 5 
-26 (pH 7.4) 
-17 (pH 5.0) 
3b 31 ± 4 63 ± 24 43 ± 15 34 ± 9 0.13 65 ± 11 
-47 (pH 7.4) 
-39 (pH 5.0) 
3c 27 ± 6 223 ± 83 153 ± 53 13 ± 2 0.40 73 ± 18 
-37 (pH 7.4) 
-32 (pH 5.0) 
 
In contrast to the good agreement between hydrodynamic and dry-state diameters 
as measured by DLS and TEM, respectively, AFM indicated significant deformation of 
3 upon deposition and drying on the mica substrate (Figure 3.4.).  The range of ca. 4–9 
nm in height and ca. 38–73 nm in diameter indicated flattening of 3, which was 
anticipated based upon the presence of low Tg fluid-like shell components, i.e., the PPE 
block segment and some degree of mixing of the shell and core components, as 
supported by the observation of a single Tg value for each block copolymer sample.  
Further quantitative analysis by AFM is complicated by the presence of substantial 
amounts of polymer debris and agglomerations of 3 across the substrate, which is also 
indicative of the fluidity of the nanoparticle assemblies. 
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Figure 3.4.  AFM height and three-dimensional images of (a) and (b) 3a: height = ca. 4 
nm and Dav = 38 ± 5 nm, (c) and (d) 3b: height = ca. 7 nm and Dav = 65 ± 11 nm, and (e) 
and (f) 3c: height = ca. 9 nm and Dav = 73 ± 18 nm, respectively, after counting more 
than 50 nanoparticles. 
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3.2.3. Preparation and Characterization of Silver-Loaded Degradable Polymeric 
Nanoparticles 
We intended to load three different silver-based compounds, i.e., from silver 
acetate (AgOAc), 1-methyl-3-(3-hydroxypropyl)-4,5-dichloroimidazol-2-ylidene silver 
(I) acetate (SCC22), or 1-methyl-3-hexyl-4,5-dichloroimidazole-2-ylidene silver (I) 
acetate (SCC10), into 3 by three different loading mechanisms as follows: (1) 
electrostatic interaction with carboxylate groups within the hydrophilic corona; (2) 
coordination with the two sulfur atoms of the 1,2-dithioether moieties on the side chains 
of the PPE block segment; and (3) encapsulation by hydrophobic interactions with the 
hydrophobic PLLA core of the nanoparticle (Figure 3.2.).  Accordingly, we 
hypothesized that manipulation of the hydrophilic block length of 3 would influence the 
degree of silver-loading capacity due to the different physical dimensions of the 
resulting 3a-c assemblies.  Furthermore, it was expected that the silver-loading site, i.e., 
shell or core, might influence the release kinetics of payloads or the antimicrobial 
therapeutic efficacy of silvers that are loaded via different loading mechanisms. 
The silver-loading capacities of 3a and 3b, selected due to their monomodal size 
distributions on DLS measurement, were analyzed by inductively coupled plasma-mass 
spectrometry (ICP-MS) using Rh as an internal standard.  Due to an ill-defined 
morphology, 3c was excluded from silver loading studies.  Overall, the loading capacity, 
measured as the weight percentage of silver loaded vs. polymers used to form the dNPs, 
was dependent on the feed amount (Figure 3.5. and Table 3.2.).  For instance, AgOAc-
3b reached ca. 8.6 wt% of silver loading capacity at the highest feed of AgOAc (40 wt% 
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with respect to the mass of polymer), as compared to ca. 3.2 wt% at 10 wt% feed 
amount.  Similarly, with 100 wt% feed of SCC22 or SCC10, ca. 11 wt% loading 
capacities were observed for 3b, which were about twice higher than when loaded at 50 
wt% feed amount.  There was no significant correlation between hydrophilic block 
length and silver-loading capacity with the two water-soluble silver compounds, AgOAc 
and SCC22.  On the basis of observations of the occurrence of precipitates or no 
improvement of silver loading upon feeds higher than 40 or 100 wt% of AgOAc or 
SCCs, respectively, and overall insignificant difference in loading % (ca. <5% in all 
cases) between 3a and 3b at 40 or 100 wt% of AgOAc or SCC22, respectively, those 
dNPs appeared to be already saturated with silver compounds regardless of the length of 
hydrophilic PPE block segment.  Meanwhile, differences in the loading efficiencies, 
measured as the ratio of silver loaded into the dNPs to the amount of silver in the feed, 
between 3a and 3b were insignificant.  Once the free silver compounds were washed 
away (Figure 3.11.), each silver-loaded micellar nanoparticle sample was lyophilizable 
and redispersible in nanopure water for experimental use. 
As characterized by DLS and TEM, Ag-3a and Ag-3b, each loaded by AgOAc, 
SCC22 or SCC10, were found to be uniform nanostructures of size and shape that agreed 
with the naked 3a and 3b, respectively, indicating that the incorporation of silver 
compounds did not affect the dimensions and morphology of the parent micellar 
assemblies (Figure 3.6., Figure 3.7. and Table 3.3.).  DLS analysis of Ag-3a and Ag-3b 
indicated Dh(number) of ca. 27 and 35 nm in average, respectively, with narrow and 
monomodal size distributions (PDI <0.26).  Also, size and size distributions of silver-
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bearing micellar nanoparticles, as observed by TEM, were comparable to those observed 
by DLS.  
 
 
Figure 3.5.  Ag-loading capacities (%) (left axis; bars) and efficiencies (%) (right axis; 
lines and symbols) of AgOAc-3a, AgOAc-3b, SCC22-3a, SCC22-3b, SCC10-3a or 
SCC10-3b with varying silver feed (i.e., 10 and 40% (w/w) of AgOAc or 50 and 100% 
(w/w) of SCC22 and SCC10 with respect to the mass of the polymers in the NP 
solutions).  (Average values were calculated from triplicate experiments.)
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Table 3.2.  Silver-loading capacity (%) and efficiency (%) of 3a and 3b with three different types of silver compounds 
(AgOAc, SCC22 and SCC10).  (Average values were calculated from triplicate.) 
  
AgOAc 
 
SCC22 SCC10 
1 
(%) 
2 
(%) 
3 
(%) 
Avg.
a 
(%)
 
Eff.
b 
(%)
 
1 
(%) 
2 
(%) 
3 
(%) 
Avg. 
(%) 
Eff. 
(%) 
1 
(%) 
2 
(%) 
3 
(%) 
Avg. 
(%) 
Eff. 
(%) 
3a 
10 
wt% 
3.52 3.63 3.63 
3.59 
± 
0.06 
55.6 ± 
0.95 
50 
wt% 
6.00 6.27 6.16 
6.14 
± 
0.13 
42.9 
± 
0.94 
4.45 4.88 4.77 
4.70 ± 
0.22 
35.1 
± 
1.66 
40 
wt% 
7.23 7.31 7.25 
7.26 
± 
0.04 
28.1 ± 
0.16 
100 
wt% 
11.8 12.0 11.9 
11.9 
± 
0.13 
41.6 
± 
0.47 
6.91 6.96 6.88 
6.92 ± 
0.04 
25.8 
± 
0.15 
3b 
10 
wt% 
3.15 3.17 3.15 
3.16 
± 
0.02 
48.8 ± 
0.23 
50 
wt% 
6.83 6.77 6.59 
6.73 
± 
0.13 
47.0 
± 
0.88 
5.41 5.39 5.25 
5.35 ± 
0.09 
40.0  
± 
0.64 
40 
wt% 
8.21 8.11 9.36 
8.56 
± 
0.69 
33.1 ± 
2.69 
100 
wt% 
10.9 11.1 11.2 
11.1 
± 
0.14 
38.8 
± 
0.49 
11.3 11.3 11.3 
11.3 ± 
0.02 
42.3  
± 
0.06 
a
Silver loading capacity, measured as the weight percentage of silver loaded vs. polymers used to form the dNPs.  (The final 
results were obtained from triplicate.) 
 
b
Silver loading efficiencies, measured as the ratio of silver loaded into the dNPs to the amount of silver in the feed.  (The final 
results were obtained from triplicate.)
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Figure 3.6.  (a, c, and e) TEM bright-field and (b, d, and f) STEM dark-field images 
(drop deposited on carbon-coated copper grids with no stain) of AgOAc-3b, SCC22-3b, 
and SCC10-3b. 
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Figure 3.7.  TEM images (drop deposited on carbon-coated copper grids and stained 
negatively with 1% (w/v) aqueous uranyl acetate) of (a) naked 3a, (b) naked 3b, (c) 
naked 3c, (d) AgOAc-3b, (e) SCC22-3b, and (f) SCC10-3b. 
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Table 3.3. Summary of characterization data from silver-loaded 3a and 3b, as measured 
by TEM and DLS. 
Composition of 
NPs 
TEM 
(nm) 
Dh(intensity) 
(nm) 
Dh(volume) 
(nm) 
Dh(number) 
(nm) 
PDI 
AgOAc-3a n/a 152 ± 123 39 ± 24 26 ± 8 0.18 
SCC22-3a n/a 162 ± 137 39 ± 24 27 ± 8 0.23 
SCC10-3a n/a 166 ± 143 41 ± 24 28 ± 8 0.26 
AgOAc-3b 27 ± 3 65 ± 22 47 ± 15 38 ± 9 0.09 
SCC22-3b 26 ± 3 67 ± 27 43 ± 16 34 ± 9 0.11 
SCC10-3b 24 ± 5 66 ± 26 45 ± 16 36 ± 9 0.08 
 
In addition to the quantitative analysis of silver amounts by using ICP-MS, we 
made an attempt to observe contrast enhancement of Ag-3b by using bright-field TEM 
and dark-field scanning transmission electron microscopy (STEM) on unstained Ag-3b 
in order to demonstrate the presence of silver within 3b (Figure 3.6.).  The detection in 
the bright-field TEM images of Ag-3b and the dark-field STEM images of distinct 
illumination of silver from Ag-3b provided strong evidence of incorporation of silver 
within 3b.  It is noteworthy that these (S)TEM samples were not stained.  Interestingly, 
hydrophobic Ag-compounds, SCC10, appeared to be located at the interface of the 
corona and core of 3b in the dark-field STEM image.  In each case, some elemental 
silver particles were detected, which may reflect reduction of Ag
+
 to Ag
0
 during the 
silver loading or TEM sample preparation processes.  For instance, as illustrated in 
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Figure 3.6., Figure 3.8. and Figure 3.9., Ag
0
 nanoparticles with metallic Ag lattice 
spacing of 2.36 nm from dAg(111) and/or 2.05 nm from dAg(200) were observed on the 
surface or inside the core of Ag-3b.  Finally, the energy-dispersive X-ray spectroscopy 
(EDX) profile strongly confirmed the presence of silver atoms in the Ag-3b sample 
along with other abundant atoms such as phosphorus, sulfur, oxygen and carbon (Figure 
3.8.). 
 
 
Figure 3.8.  STEM dark-field images (drop deposition on carbon-coated copper grids 
with no stain) and EDX spectrum profile analysis of AgOAc-3b ((a) and (b), 
respectively), SCC22- 3b ((c) and (d), respectively) and SCC10-3b ((e) and (f)), 
respectively). 
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Figure 3.9.  High-resolution TEM images with elemental silver particles, found with (a) 
AgOAc-3b, (b) SCC22-3b, and (c) SCC10-3b, which were measured to have metallic Ag 
lattice spacing = 2.36 (dAg(111)) or 2.05 Å (dAg(200)).  (For clarity, isolated elemental Ag
0
 
particles were selected to identify their lattice spacing.) 
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3.2.4. Study of Silver-Release Kinetics 
Based on the silver loading results, four representative silver-loaded micellar 
samples showing the highest loading capacities were selected for evaluation of release 
kinetics.  We measured [Ag] by ICP-MS in serial samples from dialysis cassettes in 
nanopure water at 37 ºC (Figure 3.10. and Table 3.4.).  Overall, the release kinetics of all 
of four formulations reached a plateau with almost complete silver release by ca. day 3.  
In control studies, rapid and nearly complete (> 99%) release of silver occurred for the 
silver compounds, i.e., AgOAc, SCC22 or SCC10, from dialysis cassettes in nanopure 
water within 1 hour in the absence of dNPs, demonstrating the packaging and extended 
release of the silver species from the dNP constructs.  Core-encapsulated SCC10 was 
released slightly more slowly, with time to 50% release ca. 5.5 h, than shell-loaded 
AgOAc or SCC22, ca. 2.5–3.5 h.  Similarly, 75% release of SCC10 was achieved at ca. 
17.5 h, slower than that of AgOAc and SCC22, i.e., within ca. 9.5–12 h, likely due to 
their greater aqueous phase exposure throughout the shell and on the surface of the 
particle than those entrapped in the core.  The fast release behavior of the present dNP-
based antimicrobial system could be beneficial for direct epithelial treatment and/or 
prevention of ubiquitous bacterial infections, including those of the skin and urinary 
tract.  Importantly, Ag-dNP complexes demonstrated a distinct advantage in preventing 
the reduction of silver, which was typically observed in aqueous solutions of the small 
molecule silver species within 1 day. 
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Figure 3.10.  Release profiles of silver from dialysis cassettes containing solutions of 
silver compounds (AgOAc, SCC22 or SCC10) or silver-loaded 3a and 3b at 37 °C in 
nanopure water.  (Averages were calculated from triplicate experiments.) 
 
 
Figure 3.11.  UV-vis spectra of control samples (naked 3b, AgOAc, and SCC22) and 
silver-loaded 3b after purification by centricon centrifugal filtration.  The observance of 
no signals between 380–440 nm confirmed the absence of large silver particles (ca. >10 
nm). 
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Table 3.4.  Analysis of Ag-release kinetics from Ag-loaded 3a and 3b at 37 °C in 
nanopure water (conducted in triplicate). 
 
Ag-loading 
% (w/w) 
at t=0 
Time 
Maximum  
release % 50% release 75% release 
SCC22-3a 
(100 wt% loading) 
12.3% 3.5 h 12 h 98.9% 
AgOAc-3b 
(40 wt% loading) 
9.6% 3.5 h 11 h 98.2% 
SCC22-3b 
(100 wt% loading) 
11.6% 2.5 h 9.5 h 97.9% 
SCC10-3b 
(100 wt% loading) 
10.5% 5.5 h 17.5 h 95.9% 
 
3.2.5. Degradation Studies 
In this study, we assessed the stability of hydrolytically degradable nanoparticles 
in two different pH buffer solutions, 5.0 and 7.4, at 37 °C by monitoring the changes in 
hydrodynamic diameters (Dh) and surface charges of 3b by DLS and by ζ-potential 
measurements, respectively (Figure 3.12.).  The collected hydrolytic degradation 
products were then analyzed by using 
31
P NMR spectroscopy and structurally identified 
by using electrospray ionization mass spectrometry (ESI MS).  Furthermore, 
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electrostatic interaction-dependent enzymatic degradation behavior of 3b was also 
investigated by using a lactate assay. 
 
 
Figure 3.12.  Synthetic illustration of enzymatic (left) or hydrolytic (right) degradation 
of 3b. 
 
3.2.5.1. Hydrolytic Degradation of the dNP Constructs 
The phosphoester linkage of PPEs or ester linkages of polylactides (PLAs) can 
be cleaved by spontaneous hydrolysis and/or enzymatic degradation.
95,101,104-106
  We 
hypothesized that the faster hydrolysis of phosphoester linkages of PPE, compared with 
that of ester linkages of PLLA, would decrease the ratio of 
hydrophilicity/hydrophobicity, exposing hydrophobic surface patches and resulting in 
the precipitation of dNPs as the hydrolytic degradation proceeded (Figure 3.12.).  Thus, 
aqueous buffer solutions of 3b at pH 5.0 or 7.4 were incubated at 37 °C, and degradation 
profiles were assessed by measuring changes in Dh by DLS for up to 30 days (Figure 
3.13.).  As shown in Figure 3.13., there was an apparent decrease in Dh with time, which 
might be due to hydrolytic degradation of portions of the PPE shell chains.  However, 
the degradation was complicated by macroscopic precipitation events.  Overall, the dNP 
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assemblies in pH 5.0 and 7.4 aqueous solutions became unstable within about 2 weeks at 
37 °C.  In accordance with our prediction, the dNP solutions began to form visible 
precipitates gradually as time proceeded.  After 2 weeks of incubation, a low intensity of 
scattered light prevented dNP detection, as measured by DLS.  Meanwhile, there was no 
significant change in the ζ-potential values of 3b at pH 5.0 or pH 7.4 over this time 
period (Figure 3.14.).  Finally, in agreement with our hypothesis of backbone hydrolysis 
of the PPE block segment, there was a distinct shift in the 
31
P resonance frequency from 
–0.02 ppm for intact 3b to 1.01 ppm for its degradation products, i.e., phosphoric acid 
(Figure S15). 
 
    
Figure 3.13.  Study of dNP stability by using DLS.  Changes in the hydrodynamic 
diameter (nm) of nanoparticles, 3b, at pH 5.0 (a) or pH 7.4 (b) at 37 °C over time.  The 
average values from 10 measurements, with the standard deviations calculated as the 
breadth of the distributions, are shown. 
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Figure 3.14.  Changes in ζ-potentials for 3b at pH 5.0 (black) or pH 7.4 (red) at 37 °C 
over time. 
 
 
Figure 3.15.  Changes of the 
31
P NMR resonance of PPE backbone of 3b at t=0 (black) 
(a) and t = 35 days (b) at pH 7.4 at 37 °C. 
 
3.2.5.2. Identification of the Degradation Products of 3b by ESI Mass Spectrometry. 
Previously, we reported identification of the hydrolytic degradation products of 
nanoparticles of poly(ethylene glycol)-block-polyphosphoester, a partially degradable 
diblock copolymer, by ESI MS.
95
  In the present study, we identified the degradation 
products from our fully degradable diblock copolymer system 3b by employing the same 
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analytical approach.  Solutions of 3b in D2O were incubated at 37 °C for 35 days, at 
which time they were not detectable by DLS and the 
31
P resonance signal from the intact 
PPE backbone had disappeared in 
31
P NMR spectra.  Given our hydrolytic degradation 
data, we postulated that the PPE block segment primarily becomes hydrolyzed into small 
molecules, i.e., variants of phosphoric acids along with side-chain moieties, while the 
more rigid ester backbone-based PLLA block segment would be converted into a 
mixture of oligomers and partially fragmented polymers of lactide.  Indeed, in the m/z 
region below 400, the presence of derivatives of phosphoric acids (e in Figure 3.16.) and 
side chain moieties (j in Figure 3.16.) was confirmed by ESI MS, supporting our model 
of hydrolytic degradability of phosphotriester linkages of PPE.  A number of unexpected 
molecular derivatives, generated by fragmentation during ESI MS measurements, were 
also identified by using tandem mass spectrometry (Figure 3.17.).  Of note, ethylene 
glycol was not demonstrable as one of the degradation products, as it is not ionized in 
the electrospray instrument.  In addition to the presence of the unimer and dimer of lactic 
acid (a and f in Figure 3.16., respectively) in the m/z region below 400, a series of 
fragments of PLLA block segments were detected, i.e., oligomers and polymers with 
repeat units up to 26, with monomodal distribution of m/z at intervals of 72 Da, 
corresponding to a single PLLA repeat unit.  No molecules were detected above m/z 
2000 by ESI or by matrix-assisted laser desorption/ionization time-of-flight (MALDI-
TOF) mass spectrometry. 
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Figure 3.16.  ESI MS analysis of the degradation products of nanoparticles, 3b.  Mass 
spectra in negative ion mode; m/z range of 400–2000 (a) and 50–400 (b).  See Figure 
3.17. for the MS/MS spectrum of j. 
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Figure 3.17.  MS/MS spectrum of m/z 281. 
 
3.2.5.3 Electrostatic Interaction-Induced Enzymatic Degradation of dNP Constructs 
Our group recently reported the programmed hydrolysis of polylactide-
containing nanoassemblies by electrostatic interaction-mediated enzymatic degradation 
behavior.
107
  As the present constructs feature similar chemical composition, i.e., a 
PLLA block segment, and physical features (anionic surface charge), we measured the 
electrostatic interaction-dependent enzymatic degradation rates of 3b upon the addition 
of two model enzymes possessing positive and negative charges at physiological pH, 
i.e., proteinase K (PK) with an isoelectric point (pI) ca. 8.9 and porcine liver esterase 
(PLE) with pI ca. 4.8, which can catalyze hydrolysis of poly(lactic acid).  Consistent 
with our prior observations, treatment with PK yielded ca. 40% release of lactic acid, 
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compared with ca. 4% release by porcine liver esterase (Figure 3.18.).  The accelerated 
production of lactic acid, reflecting degradation of the PLLA block segments, was 
attributed to attractive electrostatic interactions between oppositely–charged 3b and PK.  
In contrast, the limited enzymatic activity of PLE toward 3b was likely due to the 
repulsive electrostatic interaction between the two similarly charged objects, and also 
due to the lower activity of PLE vs. PK. 
 
 
Figure 3.18.  Degradation profiles of 3b in Tris-HCl buffer (100mM, pH 7.4) at 37 °C 
over 36 h, in the presence of proteinase K (black) and porcine liver esterase (red) and in 
the absence of enzyme (control, blue). 
 
3.2.6. In Vitro Antimicrobial Activity of Ag-dNPs 
It is well–known that a polymeric nanoparticle matrix may enhance the 
therapeutic efficacy of active agents by improving drug delivery features such as 
solubility, encapsulation, etc.
9
  Thus, we evaluated the in vitro antimicrobial activities of 
silver compounds and silver-loaded micelles (3a or 3b) by determining the minimal 
inhibitory concentrations (MICs) in Mueller-Hinton (MH) broth against eight 
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uropathogenic strains of E. coli and 10 contemporary strains of S. aureus.  Silver 
compounds alone and silver-loaded 3 were tested in duplicate or triplicate wells of a 96-
well plate and repeated on 3–6 separate days.  When loading 3b with each of the three 
silver species, AgOAc at 40 wt% loading, SCC22 at 100 wt% loading and SCC10 at 100 
wt% loading, comparisons were expected to be made as to the nature of the silver 
components with a common polymer micelle nanoparticle, each at their highest loading 
levels.  In addition, a fourth sample, having SCC22 loaded at 100 wt% into micelle 3a, 
allowed for comparisons of the polymer nanoparticle with the same silver species.  
Aggregate results of multiple experiments comprised 9–15 trials of each sample with 
each bacterial strain.  Overall, the MICs (expressed and compared as μg/mL Ag) of the 
silver compounds and silver-loaded nanoparticle constructs for S. aureus were higher 
than those for E. coli, but remained physiologically relevant (1–5 μg/mL) (Figure 3.19., 
Table 3.5., Table 3.6., and Table 3.7.).  Among the three silver compounds alone, 
AgOAc displayed the most potent antimicrobial activity against both bacterial species; 
the average MIC values of AgOAc were 1.89 μg/mL for E. coli and 2.84 μg/mL for S. 
aureus, compared with 3.3 and 3.98 μg/mL of SCC22 and 3.78 and 4.03 μg/mL of 
SCC10, respectively (p value of AgOAc < 0.00001 relative to that of SCC22 or SCC10 
for both E. coli and S. aureus; Table 3.7.).  Interestingly, we observed significant 
improvement of antimicrobial activity of the SCCs upon nanoparticle packaging, i.e., ca. 
50 and 70% lower MICs for SCC22-3 and SCC10-3 vs. SCC22 and SCC10, respectively 
(p values for mean MIC of SCC22-3a, SCC22-3b or SCC10-3b < 0.00001 relative to 
those of SCC22 or SCC10 for both E. coli and S. aureus).  However, similar 
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improvement was not observed when packaging AgOAc into 3b.  Although we do not 
yet fully understand the mechanism, Ag
+
 in a carbene complex appeared to be more 
efficacious with the micellar carrier system than was Ag
+
 in a salt format.  We 
previously reported a similar phenomenon.
87
  We speculate that the nanoparticle-
mediated delivery system provided protection to the SCC complexes and may have 
facilitated delivery of the silver species locally through nonspecific association of the 
nanoparticles with the bacterial cells.  Of note, naked 3, with no silver loading and 
applied at equivalent polymer concentrations, did not display antimicrobial activity nor 
toxicity to cultured mammalian cells.  Taken together, these Ag-dNPs exhibited 
antimicrobial activities superior to small silver compounds, which supports the potential 
of using the developed degradable nanoparticles as an antimicrobial delivery system.   
 
  
Figure 3.19.  Minimum inhibitory concentration (MIC, μg/mL Ag) profiles of silver-
compounds (AgOAc, SCC22 and SCC10) and silver-bearing micellar nanoparticles 
(AgOAc-3b, SCC22-3a, SCC22-3b and SCC10-3b) against (a) eight uropathogenic 
strains of E. coli and (b) 10 contemporary epidemic strains of S. aureus. 
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Table 3.5.  Average MICs (μg/mL Ag) and % improvements of silver compounds 
.(AgOAc, SCC22 and SCC10) and silver-bearing micellar nanoparticles (AgOAc-3b, 
SCC22-3a, SCC22-3b, and SCC10-3b) against eight uropathogenic strains of E. coli. 
 AgOAc SCC22 SCC10 
Avg. MIC 1.89 3.3 3.78 
 AgOAc-3b SCC22-3a SCC22-3b SCC10-3b 
Avg. MIC 1.65 1.73 1.6 1.15 
% 
Improvement 
13% 48% 52% 70% 
 
Table 3.6.  Average MICs (μg/mL Ag) and % MIC improvement for silver compounds 
(AgOAc, SCC22 and SCC10) and silver-bearing micellar nanoparticles (AgOAc-3b, 
SCC22-3a, SCC22-3b and SCC10-3b) against 10 contemporary epidemic strains of S. 
aureus. 
 AgOAc SCC22 SCC10 
Avg. MIC 2.84 3.98 4.03 
 AgOAc-3b SCC22-3a SCC22-3b SCC10-3b 
Avg. MIC 2.82 2.16 1.97 1.34 
% 
Improvement 
1% 46% 51% 67% 
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Table 3.7.  Minimum inhibitory concentrations (MICs) and statistical significance (p) values of parent silver compounds 
(AgOAc, SCC22 and SCC10) and silver-bearing micellar nanoparticles (AgOAc-3b, SCC22-3a, SCC22-3b and SCC10-3b) 
against 8 uropathogenic strains of E. coli and 10 contemporary epidemic strains of S. aureus.  (Note: p values for MIC 
comparisons of silver-bearing micellar nanoparticles vs. parent silver compounds are shown.) 
E. coli SCC22 SCC22-3a 
p vs 
SCC22 
SCC22-3b 
p vs 
SCC22 
AgOAc AgOAc-3b 
p vs 
AgOAc 
SCC10 SCC10-3b 
p vs 
SCC10 
UTI89 3.64±1.01 1.73±0.8 <0.001 1.63±0.77 <0.001 2.07±1.03 1.77±0.73 0.3658 3.87±1.55 1.3±0.62 < 0.001 
MG1655 3.86±1.83 2.2±0.94 <0.005 2.03±0.77 <0.001 2.23±1.25 1.37±0.9 0.0378 4.33±1.84 1.17±0.72 < 0.001 
CFT073 2.87±1.13 1.07±0.62 <0.001 0.93±0.5 <0.001 1.13±0.58 1.1±0.69 0.8869 2.47±1.19 0.7±0.25 < 0.001 
1298 2.21±1.31 1.43±1.07 <0.089 1.2±0.82 <0.018 1.7±1.05 1.27±0.75 0.2042 3.53±1.25 0.97±0.67 < 0.001 
408 3.33±1.18 1.73±0.8 <0.001 1.53±0.64 <0.001 1.8±0.68 1.53±0.81 0.3368 3.87±1.06 1.17±0.65 < 0.001 
277 2.86±1.17 1.63±0.77 <0.002 1.43±0.78 <0.001 1.7±0.84 1.6±0.87 0.7513 3.73±1.62 1.2±0.62 < 0.001 
1-Dec 3.13±1.19 1.5±0.85 <0.001 1.5±1.07 <0.001 1.73±0.8 1.7±0.92 0.9165 3.73±1.22 1±0.34 < 0.001 
P-31 4.47±1.25 2.53±0.52 <0.001 2.53±0.74 <0.001 2.73±0.96 2.87±0.99 0.7111 4.73±1.03 1.68±0.87 < 0.001 
mean 3.3 1.73  1.6  1.89 1.65  3.78 1.15  
14–15 wells 
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Table 3.7.  Continued. 
S. aureus SCC22 SCC22-3a 
p vs 
SCC22 
SCC22-3b 
p vs 
SCC22 
AgOAc AgOAc-3b 
p vs 
AgOAc 
SCC10 SCC10-3b 
p vs 
SCC10 
6222N 4±2.29 2.17±1.52 <0.063 1.94±1.26 0.031 2.83±1.8 2.83±1.8 1 4±1.7 1.17±0.7 < 0.001 
6266.1G 4±2.29 2.17±1.52 <0.063 1.94±1.26 0.031 3.06±2 2.83±1.8 0.802 4±1.7 1.17±0.7 < 0.0 
6219G 4.33±1.8 2.17±1.52 <0.014 2.17±1.52 0.014 3.17±2 3±1.5 0.8463 4±1.7 1.5±0.8 0.001 
6247W 4.33±1.8 2.17±1.52 <0.014 2.17±1.52 0.014 3.33±1.8 3±1.5 0.6755 4±1.7 1.5±0.8 0.001 
6319W 3.89±1.69 2.17±1.52 <0.037 1.83±1.09 0.007 2.83±1.8 2.83±1.8 1 4±1.7 1.72±1 0.004 
6210W 3.89±1.69 2.17±1.52 <0.037 1.83±1.09 0.007 2.83±1.8 2.83±1.8 1 4±1.7 1.17±0.7 < 0.001 
6328A 3.67±2 2.17±1.52 <0.092 1.83±1.09 0.028 2.83±1.8 2.83±1.8 1 4±1.7 1.17±0.7 < 0.001 
6356N 3.33±1.8 1.94±1.26 <0.076 1.83±1.09 0.048 2.17±1.5 2.17±1.5 1 4±1.7 1.17±0.7 <0.00±1 
6419W 4±2.29 2.17±1.52 <0.063 2.17±1.52 0.063 3.06±2 2.89±1.7 0.8486 4±1.7 1.5±1.1 0.002 
6430W 4.33±1.8 2.28±1.39 <0.016 1.94±0.95 0.003 2.33±1.3 3±1.5 0.3322 4.33±1.3 1.39±1 < 0.001 
mean 3.98 2.16  1.97  2.84 2.82  4.03 1.34  
  9 wells
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3.3. Experimental Section 
3.3.1.  Materials 
Ammonium acetate, benzoic acid, 3-butyn-1-ol, dimethyl sulfoxide (DMSO), 
2,2-dimethoxy-2-phenylacetophenone, 3-mercaptopropionic acid, 3-(N-
morpholino)propanesulfonic acid (MOPS), porcine liver esterase (PLE) (activity = 154 
U mg
-1
, concentration = 35.6 mg of protein mL
-1
), proteinase K (PK) (activity = 1362 U 
mL
-1
, concentration = 36 mg of protein mL
-1
), silver acetate (AgOAc) and triethylamine 
(TEA) were used as received from Sigma-Aldrich Company.  2-Chloro-2-oxo-1,3,2-
dioxaphospholane (COP, 95%) was used as received from Thermo Fisher Scientific Inc.  
L-Lactide (LLA) (98%, Alfa Aesar) was purified and dried by azeotropic distillation in 
toluene three times.  Benzyl alcohol and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) 
were purchased from Sigma-Aldrich Company, and they were distilled from calcium 
hydride.  The dried benzyl alcohol, DBU and LLA were stored in an argon-filled 
glovebox until use.  Tetrahydrofuran (THF) and dichloromethane (DCM) were dried 
through columns (J. C. Meyer Solvent Systems, Inc.).  1-Methyl-3-(3-hydroxypropyl)-
4,5-dichloroimidazol-2-ylidene silver (I) acetate (silver carbene complex 22, SCC22) 
and 1-methyl-3-hexyl-4,5-dichloroimidazole-2-ylidene silver (I) acetate (silver carbene 
complex 10, SCC10) were synthesized as previously reported.
108,109
  Spectra/Pro 
membranes (MWCO 12‒14 kDa, Spectrum Medical Industries, Inc., Laguna Hills, CA) 
were used for dialysis.  The cell culture 96-well flat bottom plates were purchased from 
Corning Costar Co.  Amicon ultra centrifugal filter devices (100 kDa MWCO) were 
purchased from Millipore Corp (Bedford, MA).  Nanopure water (18 MΩ·cm) was 
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acquired by means of a Milli-Q water filtration system (Millipore Crop., Bedford, MA).  
The lactate colorimetric assay kit (ab65331) was purchased from Abcam.  Dialysis 
cassettes (Slide-A-Lyzer, 10 kDa MWCO) were purchased from Pierce Biotechnology, 
Rockford, IL. 
3.3.2.  Characterization Methods 
1
H, 
13
C, and 
31
P NMR spectra were recorded on Inova 300 MHz spectrometers 
interfaced to UNIX computers using VnmrJ software.  Chemical shifts were referenced 
to solvent resonance signals.  For 
31
P NMR spectroscopy, phosphoric acid (85 wt% in 
H2O) at 0 ppm was used as an external standard.  IR spectra were recorded on an IR 
Prestige 21 system (Shimadzu Corp., Japan) and analyzed using the IRsolution software. 
Size exclusion chromatography (SEC) measurements were performed on a 
Waters Chromatography, Inc. (Milford, MA) system equipped with an isocratic pump 
model 1515, a differential refractometer model 2414, and a four-column set of 5 μm 
Guard (50 × 7.5 mm), Styragel HR 4 5 μm DMF (300 × 7.5 mm), Styragel HR 4E 5 μm 
DMF (300 × 7.5 mm) and Styragel HR 2 5 μm DMF (300 × 7.5 mm).  Polymer solutions 
were prepared at a concentration of about 3–5 mg/mL and an injection volume of 200 μL 
was used.  Data collection and analysis were performed with Empower 2 v. 6.10.01.00 
software (Waters, Inc.).  The system was equilibrated at 70 °C in pre-filtered DMF 
containing 0.05 M of LiBr, which served as polymer solvent and eluent (flow rate set to 
1.00 mL/min).  The system was calibrated with polystyrene standards (Polymer 
Laboratories, Amherst, MA) ranging from 615 to 442800 Da. 
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Glass transition temperatures were measured by differential scanning calorimetry 
(DSC) on a Mettler-Toledo DSC822 (Mettler-Toledo, Inc., Columbus, OH), with a 
heating rate of 10 °C/min.  Measurements were analyzed by using Mettler-Toledo Star
e
 
v. 7.01 software.  The Tg was taken as the midpoint of the inflection tangent, upon the 
third heating scan.  Thermogravimetric analysis (TGA) was performed under N2 
atmosphere using a Mettler-Toledo model TGA/SDTA851e, with a heating rate of 10 
°C/min and cooling rate of 10 °C/min.  Measurements were analyzed by using Mettler-
Toledo Star
e
 v. 7.01 software. 
Dynamic light scattering (DLS) measurements were conducted using Delsa Nano 
C (Beckman Coulter, Inc., Fullerton, CA) equipped with a laser diode operating at 658 
nm.  Size measurements were made in nanopure water (n = 1.3329, ƞ = 0.890 cP at 25 ± 
1°C).  Scattered light was detected at 165° angle and analyzed using a log correlator over 
70 accumulations for a 3.0 mL sample in a glass sizing cell (4.0 mL capacity).  The 
samples in the glass sizing cell were equilibrated for 30 min before measurements were 
made.  The photomultiplier aperture and the attenuator were automatically adjusted to 
obtain a photon counting rate of ca. 10 kcps.  Calculation of the particle size distribution 
and distribution averages was performed using CONTIN particle size distribution 
analysis routines.  The peak averages of histograms from number distributions out of 70 
accumulations were reported as the average diameters of the particles. 
The ζ-potential values of the nanoparticles were determined by Delsa Nano C 
particle analyzer (Beckman Coulter, Fullerton, CA) equipped with a 30 mW dual laser 
diode (658 nm).  The ζ-potential values of the particles in suspension were obtained by 
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measuring the electrophoretic movement of charged particles under an applied electric 
field.  Scattered light was detected at a 30° angle at 25 °C.  The ζ-potential was 
measured at five regions in the flow cell and a weighted mean was calculated.  These 
five measurements were used to correct for electroosmotic flow that was induced in the 
cell due to the surface charge of the cell wall.  All determinations were repeated three 
times. 
Transmission electron microscopy (TEM) images were collected on a JEOL 
1200EX, operating at 100 kV or a FEI Tecnai G2 F20 FE-TEM, operating at a voltage of 
200 kV.  High-resolution scanning transmission electron (STEM) microscopy was 
conducted on a FEI Tecnai G2 F20 FE-TEM coupled with energy-dispersive X-ray 
(EDX), operating at a voltage of 200 kV.  The samples, as aqueous solution (5 µL, 
polymer concentration at 0.25–3.75 mg/mL), was deposited onto carbon-coated copper 
grids.  After 1 min of deposition, the excess sample was quickly wicked off by using 
filter paper, and the grids were allowed to dry in the air for 10 min.  Then, the grids were 
negatively stained with 5 µL of a 2% aqueous solution of uranyl acetate.  The excess 
stain was wicked off using filter paper after 20 seconds.  The sample grids were dried 
under vacuum at room temperature overnight before analysis.   
Atomic force microscopy (AFM) was performed using a Multimode 8 system 
(Bruker) with an SA Fluid+ silicon probe (k 0.7 N/150 kHz, Bruker).  For AFM 
preparation, nanoparticles were dissolved in nanopure water at 0.1 mg/mL, and 20 μL of 
the sample was spin coated onto a glass coverslip.  All AFM samples were stored at 
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room temperature in a vacuum desiccator until use.  AFM images were assessed with 
Nanoscope Analysis (Bruker). 
Electrospray ionization (ESI) in negative ion mode was carried on a quadruple 
ion trap mass spectrometer (LCQ-DECA, ThermoFinnigan, San Jose, CA).  The sample 
was directly infused at 6 µL/min of flow rate.  The spray voltage was set at –4.5 kV.  
Sheath gas and auxiliary gas flow rates were 50 and 10 arbitrary units, respectively.  
Transfer capillary temperature was held at 250 °C.  MS/MS experiments were performed 
on the same instrument at a relative collision energy of 30−32%.  Xcalibur 2.0 software 
package (ThermoFinnigan) was used for data acquisition and processing. 
Matrix-assisted laser desorption ionization (MALDI) experiments were 
performed on a Voyager DE-STR mass spectrometer (Applied Biosystems, Foster City, 
CA) under optimized conditions in positive linear mode.  Ions were generated by a 
pulsed nitrogen laser at 337 nm and accelerated through 25 kV and 100 laser shots were 
used per spectrum.  Trans-2-[3-(4-t-Butyl-phenyl)-2-methyl-2-propenylidene] 
malononitrile (DCTB) and potassium trifluoroacetate (KTFA) were used as a matrix and 
cationization reagent, respectively.  The sample, KTFA, and matrix were prepared at 
concentration of 1, 10, and 20 mg/mL respectively.  The sample solution was mixed with 
the matrix and KTFA at a volume ratio of 1:5:1.  About 0.5 µL of this mixture was 
deposited on a stainless steel sample holder.  After being allowed to air dry, the sample 
was analyzed using MALDI-TOF MS. 
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Ultraviolet–visible spectroscopy (UV–vis) absorption measurements were made 
using a UV-2550 system (Shimadzu Corp.).  Measurements were performed in nanopure 
water in quartz cuvettes with path lengths of 1 cm. 
Critical micelle concentration (CMC) values were determined by pyrene 
fluorescence measurements that were conducted on a RF-5301PC 
spectrofluorophotometer system (Shimadzu Corp., Kyoto, Japan) and analyzed using 
Panorama Fluorescence v. 2.1 software.  Fluorescence emission spectra ranging from 
360 to 450 nm of the sample solutions were recorded using an excitation wavelength of 
334 nm at room temperature.  Each measurement was repeated in triplicate. 
Inductively coupled plasma-mass spectrometry (ICP-MS) was performed on a 
PerkinElmer SCIEX ICP mass spectrometer ELAN DRC II, equipped with high-speed 
quadrupole, dynamic reaction cell (DRC) and axial field technology (AFT) to 
completely eliminate polyatomic interferences, using 1% HNO3 as the matrix and 
rhodium (Rh) as the internal standard. 
Analysis of lactic acid by the colorimetric assay was made on a SpectraMax M5 
microplate reader. 
3.3.3. Synthesis of Monomer, 2-(But-3-yn-1-yloxy)-2-oxo-1,3,2-dioxaphospholane 
(BYP) 
A solution of COP (14.9936 g, 105 mmol) in 50 mL of anhydrous THF was 
added dropwise to a stirred solution of 3-butyn-1-ol (8.1270 g, 116 mmol) and TEA (17 
mL, 12 g, 120 mmol) in 200 mL of anhydrous THF at 4 °C.  The reaction mixture was 
allowed to stir for 11 h at 4 °C and then for 30 min at room temperature.  The precipitate 
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was filtered off, and the filtrate was concentrated under reduced pressure.  The filtrate 
was distilled under reduced pressure to obtain a faint yellow and viscous liquid 
(110120 °C, 0.5 mmHg) with a yield of 52.3%, 9.67 g,  IR: 33303170, 30502870, 
1474, 1283, 1009, 926, 835, 756 cm
-1
.  
1
H NMR (CDCl3, ppm): δ 4.504.31 (m, 4H, 
POCH2CH2OP), 4.21 (dt, J = 9.3 Hz, J = 6.9 Hz, 2H, POCH2CH2C), 2.59 (ddt, J = 6.9 
Hz, 2.4 Hz, 0.3 Hz, 2H, POCH2CH2C), 2.02 (t, J = 2.7 Hz, 1H, POCH2CH2CCH).  
13
C 
NMR (CDCl3, ppm): δ 79.21, 70.58, 66.34 (d, J = 23.7 Hz), 66.14 (d, J = 10.2 Hz), 
20.82 (d, J = 25.5 Hz).  
31
P NMR (CDCl3, ppm): δ 18.02.  +ESI MS: calculated [M+H]
+
 
for C6H9O4P: 177.0317, found: 177.0311. 
3.3.4. Synthesis of Diblock Copolymer, Poly(butynyl phosphotriester)50-block-Poly(L-
lactide)50 (PPE50-b-PLLA50) 
In a glovebox, a solution of BYP (3.0226 g, 17.2 mmol) and benzyl alcohol (35.3 
µL, 37.0 mg, 0.340 mmol) in anhydrous DCM (3.0 mL) was transferred into a vial with 
a stir bar.  DBU (102 µL, 104 mg, 0.682 mmol) was added via pipet into the mixture 
solution.  After the mixture stirred for 7 min, a solution of LLA (2.4615 g, 17.1 mmol) in 
anhydrous DCM (21 mL) was quickly added into the mixture solution.  After 4 min, the 
reaction was quenched by addition of a solution of benzoic acid in DCM (excess).  The 
product was precipitated in diethyl ether (3×) and dried overnight under vacuum to 
afford the diblock copolymer product as a tacky white solid (4.9787 g, 91% yield).  
GPC: Mn = 21800 g/mol, PDI = 1.17.  IR: 33503150, 30502850, 1757, 1456, 1271, 
1211, 1184, 1130, 1074, 1009, 970, 804 cm
-1
.  
1
H NMR (CD2Cl2, ppm): δ 7.447.32 (m, 
5H, aromatic ring), 5.16 (broad q, J = 7.2 Hz, 102H, ArCH2OP and OCCH(O)CH3), 
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4.404.22 (b, 200H, POCH2CH2O), 4.224.08 (b, 100H, POCH2CH2CCH), 2.672.54 
(b, 100H, POCH2CH2CCH), 2.28–2.09 (b, 50H, OCH2CH2CCH), 1.55  (broad d, J = 7.2 
Hz, 300H, CH3CH(O)CO).  
13
C NMR (CD2Cl2, ppm): δ 170.02, 130.07, 129.16, 128.57, 
80.28, 71.00, 69.53, 67.00, 66.27, 21.06, 17.02.  
31
P NMR (CD2Cl2, ppm): δ –1.02.  
DSC: Tg = -33 °C.  TGA in N2: 190-290 °C, 40% mass loss; 290370 °C, 42% mass 
loss; 12% mass remaining above 370 °C. 
3.3.5. Synthesis of Diblock Copolymer, Poly(butynyl phosphotriester)90-block-Poly(L-
lactide)50 (PPE90-b-PLLA50) 
In a glovebox, a solution of BYP (2.0014 g, 11.4 mmol) and benzyl alcohol (11.8 
µL, 12.3 mg, 0.114 mmol) in anhydrous DCM (2.0 mL) was transferred into a vial with 
a stir bar.  DBU (34 µL, 34.6 mg, 0.228 mmol) was added via pipet into the mixture 
solution.  After the mixture stirred for 8 min, a solution of LLA (1.6434 g, 11.4 mmol) in 
anhydrous DCM (14.2 mL) was quickly added via pipet into the reaction mixture.  After 
4.5 min, the reaction was quenched by addition of a solution of benzoic acid in DCM 
(excess).  The product was precipitated in diethyl ether (3×) and dried overnight under 
vacuum to afford the diblock copolymer product as a tacky white solid (2.0574 g, 78% 
yield).  GPC: Mn = 22400 g/mol, PDI = 1.25.  IR: 3350–3150, 3050–2850, 1757, 1454, 
1383, 1360, 1271, 1211, 1186, 1130, 1072, 1011, 970, 860, 802, 752 cm
-1
.  
1
H NMR 
(CD2Cl2, ppm): δ 7.44–7.32 (m, 5H, aromatic ring), 5.17 (broad q, J = 7.2 Hz, 102H, 
ArCH2OP and OCCH(O)CH3), 4.38–4.22 (b, 360H, POCH2CH2O), 4.22–4.10 (b, 180H, 
POCH2CH2CCH), 2.68–2.53 (b, 180H, POCH2CH2CCH), 2.24–2.07 (b, 90H, 
OCH2CH2CCH), 1.56 (broad d, J = 7.2 Hz, 300H, CH3CH(O)CO).  
13
C NMR (CD2Cl2, 
 73 
 
ppm): δ 170.02, 129.16, 128.57, 80.28, 71.00, 69.52, 67.00, 66.26, 21.06, 17.02.  31P 
NMR (CD2Cl2, ppm): δ –1.02.  DSC: Tg = -29 °C.  TGA in N2: 275 °C, 35 % mass loss; 
350 °C, 32 % mass loss; 32 % mass remaining above 350 °C.  
3.3.6. Synthesis of Diblock Copolymer, Poly(butynyl phosphotriester)210-block-
Poly(L-lactide)50 (PPE210-b-PLLA50) 
In a glovebox, a solution of BYP (1.9973 g, 11.3 mmol) and benzyl alcohol (3.9 
µL, 4.1 mg, 0.038 mmol) in anhydrous DCM (2.3 mL) was transferred into a vial with a 
stir bar.  DBU (17 µL, 17 mg, 0.11 mmol) was added via pipet into the reaction mixture.  
After the mixture stirred for 30 min, a solution of LLA (0.5451 g, 3.78 mmol) in 
anhydrous DCM (3.4106 mL) was quickly added via pipet into the reaction mixture.  
After 4.5 min, the reaction was quenched by addition of a solution of benzoic acid in 
DCM (excess).  The product was precipitated in diethyl ether (3×) and dried overnight 
under vacuum to afford the diblock copolymer product as a tacky white solid (1.3689 g, 
82% yield).  GPC: Mn = 45600 g/mol, PDI = 1.26.  IR: 3325–3125, 3025–2825, 1757, 
1454, 1383, 1267, 1188, 1128, 1072, 1009, 972, 847, 804, 735 cm
-1
.  
1
H NMR (CD2Cl2, 
ppm): δ 7.44–7.32 (m, 5H, aromatic ring), 5.16 (broad q, J = 7.2 Hz, 102H, ArCH2OP 
and OCCH(O)CH3), 4.38–4.22 (b, 840H, POCH2CH2O), 4.22–4.10 (b, 420H, 
POCH2CH2CCH), 2.68–2.53 (b, 420H, POCH2CH2CCH), 2.24–2.07 (b, 210H, 
OCH2CH2CCH), 1.56 (broad d, J = 7.2 Hz, 300H, CH3CH(O)CO).  
13
C NMR (CD2Cl2, 
ppm): δ 170.02, 129.15, 128.57, 80.27, 70.99, 69.52, 67.01, 66.26, 21.05, 17.01.  31P 
NMR (CD2Cl2, ppm): δ –1.03.  DSC: Tg = -42 °C.  TGA in N2: 275 °C, 45 % mass loss; 
360 °C, 20 % mass loss; 360 °C, 35 % mass remaining above 360 °C. 
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3.3.7. Thiol-yne “Click” Reaction of Alkyne Side Chain Moieties of PPE Block of 
PPE50-b-PLLA50 with 3-Mercaptopropionic Acid, 2a 
A solution of PPE50-b-PLLA50 (0.1493 g, 0.00990 mmol), 3-mercaptopropionic 
acid (0.430 mL, 4.93 mmol) and 2,2-dimethoxy-2-phenylacetophenone (0.2153 g, 0.840 
mmol) in 7.5 mL of DMSO was irradiated under UV irradiation (365 nm, 6 W) for 60 
min while stirring.  Purification included precipitation in diethyl ether (3×), followed by 
dialysis in nanopure water, and isolation of the product by freeze-drying overnight to 
give a tacky white solid (0.1892 mg, 75 % yield).  IR: 36752760, 27002430, 1757, 
1715, 1452, 1408, 1385, 1184, 1130, 1086, 1016, 982, 802, 754 cm
-1
.  
1
H NMR (DMSO-
d6, ppm): δ 13.211.9 (b, SCH2CH2C(O)OH), 7.447.26 (m, 5H, aromatic ring), 5.46 (d, 
J = 7.2 Hz, 2H, ArCH2O), 5.20 (broad q, J = 7.2 Hz, 100H, OCCH(O)CH3), 4.503.80 
(b, 300H, POCH2CH2O and POCH2CH2CH), 3.002.81 (b, 200H, SCH2CH2COOH), 
2.802.62 (b, 250H, SCH2CH2COOH and SCH(CH2)CH2CH2), 2.602.50 (b, 100H, 
SCH2CHS), 2.252.05 and 1.851.57 (b, 100H, POCH2CH2CH), 1.46 (broad d, J = 7.2 
Hz, 300H, OCCH(O)CH3).  
13C NMR (DMSO, ppm): δ 173.05, 172.19, 169.27, 68.72, 
66.25, 65.34, 44.05, 42.91, 41.67, 38.19, 37.54, 34.73, 34.18, 33.53, 29.71, 27.18, 26.09, 
25.22, 16.53.  
31P NMR (DMSO, ppm): δ –0.03.  DSC: Tg = 6 °C.  TGA in N2: 105190 
°C, 13% mass loss; 190280 °C, 40% mass loss; 280350 °C, 25% mass loss; 22% mass 
remaining above 350 °C. 
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3.3.8. Thiol-yne “Click” Reaction of Alkyne Side Chain Moieties of PPE Block of 
PPE90-b-PLLA50 with 3-Mercaptopropionic Acid, 2b 
A solution of PPE90-b-PLLA50 (0.1014 mg, 0.00437 mmol), 3-mercaptopropionic 
acid (0.34 mL, 3.90 mmol) and 2,2-dimethoxy-2-phenylacetophenone (0.1975 g, 0.771 
mmol) in 7.5 mL of DMSO was irradiated under UV irradiation (365 nm, 6 W) for 60 
min while stirring.  Purification included precipitation in diethyl ether (3×), followed by 
dialysis in nanopure water, and isolation of the product by freeze-drying overnight to 
give a tacky white solid (0.1512 mg, 82 % yield).  IR: 3375–2775, 2715–2400, 1713, 
1404, 1180, 1130, 1074, 1020, 955, 799 cm
-1
.  
1
H NMR (DMSO, ppm): δ 13.2–12.2 (b, 
SCH2CH2C(O)OH), 7.45–7.30 (m, 5H, aromatic ring), 5.20 (broad q, J = 7.2 Hz, 100H, 
OCCH(O)CH3), 4.35–3.70 (b, 540H, POCH2CH2O and POCH2CH2CH), 3.00–2.80 (b, 
360H, SCH2CH2COOH), 2.80–2.64 (b, 450H, SCH2CH2COOH and 
SCH(CH2)CH2CH2), 2.58–2.42 (b, 180H, SCH2CHS), 2.25–2.05 and 1.85–1.60 (b, 
180H, POCH2CH2CH), 1.46 (broad d, J = 7.2 Hz, 300H, OCCH(O)CH3).  
13
C NMR 
(DMSO, ppm): δ 172.86, 172.13, 169.21, 68.68, 64.56, 47.13, 46.80, 44.02, 42.92, 
36.79, 34.82, 34.16, 29.27, 26.14, 16.49.  
31
P NMR (DMSO, ppm): δ –0.02.  DSC: Tg = 
5 °C.  TGA in N2: 250 °C, 48 % mass loss; 365 °C, 28 % mass loss; 24 % mass 
remaining above 365 °C. 
3.3.9. Thiol-yne “Click” Reaction of Alkyne Side Chain Moieties of PPE Block of 
PPE210-b-PLLA50 with 3-Mercaptopropionic Acid, 2c 
A solution of PPE210-b-PLLA50 (0.1983 mg, 0.00448 mmol), 3-
mercaptopropionic acid (0.83 g, 9.52 mmol) and 2,2-dimethoxy-2-phenylacetophenone 
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(0.4769 g, 1.86 mmol) in 9 mL of DMSO was irradiated under UV irradiation (365 nm, 
6 W) for 60 min while stirring.  Purification included precipitation in diethyl ether (3×), 
followed by dialysis in nanopure water, and isolation of the product by freeze-drying 
overnight to give a tacky white solid (0.3452 g, 86.0 % yield).  IR: 3675–2775, 2775–
2350, 1713, 1404, 1182, 1130, 1020, 974, 953, 799 cm
-1
.  
1H NMR (DMSO, ppm): δ 
13.6–12.2 (b, SCH2CH2C(O)OH), 7.45–7.30 (m, 5H, aromatic ring), 5.20 (broad q, J = 
7.2 Hz, 100H, OCCH(O)CH3), 4.30–3.65 (b, 1260H, POCH2CH2O and POCH2CH2CH), 
3.00–2.78 (b, 840H, SCH2CH2COOH), 2.78–2.65 (b, 1050H, SCH2CH2COOH and 
SCH(CH2)CH2CH2), 2.60–2.40 (b, 420H, SCH2CHS), 2.30–2.08 and 1.85–1.55 (b, 
420H, POCH2CH2CH), 1.46 (broad d, J = 6.9 Hz, 300H, OCCH(O)CH3.  
13
C NMR 
(DMSO, ppm): δ 172.87, 172.16, 169.21, 164.52, 68.68, 47.19, 46.80, 44.02, 42.96, 
36.85, 34.91, 34.17, 29.28, 26.29, 16.48.  
31P NMR (DMSO, ppm): δ -0.02.  DSC: Tg = -
10 °C.  TGA in N2: 260 °C, 53 % mass loss; 350 °C, 14 % mass loss; 33 % mass 
remaining above 350 °C.  
3.3.10. General Procedure for Self-Assembly of Amphiphilic Diblock Copolymers, 
Anionic Polyphosphoester-block-Poly(L-lactide) (aPPE-b-PLLA), 2 
A total of 1.0 mg of 2 was suspended in nanopure water (for TEM and AFM 
analyses), MOPS buffer (50 mM, pH 7.4) or ammonium acetate buffer (50 mM, pH 5.0) 
(for DLS and ζ-potential measurements) in a vial, and the mixture was stirred for 30 min 
at room temperature prior to sample preparation. 
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3.3.11. Determination of Critical Micelle Concentrations (CMCs) for 2 To Afford 
Micelles 3 in Nanopure Water 
The CMCs for 2a, 2b or 2c in nanopure water were determined using pyrene as 
the fluorescent probe following the protocol in literature.
110
  A total volume of 0.75 mL 
of sample solution was prepared by mixing 2 in nanopure water (ranging from ca. 0.01–
3.5 mg/mL) with a pyrene aqueous stock solution (0.250 mL, 6.0 × 10
-7
 mol/L).  All the 
sample solutions were then stored at room temperature for 1 followed by storage at 4 ºC 
overnight to equilibrate the pyrene and the micelles.  The fluorescence measurement was 
conducted at room temperature, in which the pyrene was excited at 334 nm and its 
emission spectrum was recorded at 373 and 384 nm, corresponding to the first and third 
vibrational peaks, respectively.  All measurements were repeated in triplicate and the 
ratios of intensities of the first (II) and third (IIII) peaks were plotted against the 
concentrations of 3 in the sample solutions.  The CMC was taken as the intersection of 
the tangent to the curve at the inflection with tangent through the points at lower 
polymer concentration. 
3.3.12. General Procedure for the Preparation of AgOAc-Loaded Degradable 
Polymeric Nanoparticles (AgOAc-3) 
A solution of AgOAc (4 mg/mL in nanopure water) was added dropwise to a 
solution of 2 (1.5 mL, polymer concentration = 5 mg/mL).  The solution was shielded 
from light and allowed to stir overnight at room temperature.  Then, the solution was 
washed thoroughly with nanopure water (>4 cycles) to remove free small silver-
compounds by using a centrifugal filter device (100 kDa MWCO).  The absence of free 
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Ag
+
 from the mixture solution was confirmed by observing no occurrence of precipitates 
(AgCl) upon adding a saturated solution of sodium chloride to the filtrate.  The resulting 
solution of AgOAc-3 was reconstituted to a final volume of 2 mL, and silver 
concentration was measured by ICP-MS.  Aliquots of the solution of AgOAc-3 were 
used for UV–vis, TEM and DLS measurements. 
3.3.13. General Procedure for the Preparation of SCC22-Loaded Degradable 
Polymeric Nanoparticles (SCC22-3) 
A solution of SCC22 (10 mg/mL in nanopure water) was added dropwise to the 
solution of 2 (1.5 mL, polymer concentration = 5 mg/mL).  The solution was shielded 
from light and allowed to stir overnight at room temperature.  Then, the solution was 
washed thoroughly with nanopure water (>4 cycles) to remove free small silver-
compounds by using a centrifugal filter device (100 kDa MWCO).  The absence of free 
Ag
+
 from the mixture solution was confirmed by observing no occurrence of precipitates 
(AgCl) upon adding a saturated solution of sodium chloride to the filtrate.  The resulting 
solution of SCC22-3 was reconstituted to a final volume of 2 mL, and silver 
concentration was measured by ICP-MS.  Aliquots of the solution of SCC22-3 were 
used for UV–vis, TEM and DLS measurements. 
3.3.14. General Procedure for the Preparation of SCC10-Loaded Degradable 
Polymeric Nanoparticles (SCC10-3) 
A solution of SCC10 (10 mg/mL in CHCl3) was added dropwise to a solution of 
2 (1.5 mL, polymer concentration = 5 mg/mL).  The solution was shielded from light 
and allowed to stir vigorously to form a water/CHCl3 emulsion overnight at room 
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temperature.  After evaporation of the organic solvent overnight, the solution was 
washed thoroughly with nanopure water (>4 cycles) to remove free small silver-
compounds by using a centrifugal filter device (100 kDa MWCO).  The absence of free 
Ag
+
 from the mixture solution was confirmed by observing no occurrence of precipitates 
(AgCl) upon adding a saturated solution of sodium chloride into the filtrate.  The 
resulting solution of SCC10-3 was reconstituted to a final volume of 2 mL, and silver 
concentration was measured by ICP-MS.  Aliquots of the solution of SCC10-3 were 
used for UV–vis, TEM and DLS measurements. 
3.3.15. General Procedure for Study of Silver Release Kinetics of Silver Compounds 
(AgOAc, SCC22 or SCC10) and Ag-3 (Loaded by AgOAc, SCC22, or SCC10) 
Into a presoaked dialysis cassette (Slide-A-Lyzer, 10 kDa MWCO, Pierce 
Biotechnology, Rockford, IL) was transferred a  solution of silver compounds or Ag-3 (3 
mL) was transferred.  The dialysis cassette was incubated in nanopure water at 37 °C for 
5 days.  For SCC10, it was dissolved in THF, and the solution was transferred into the 
dialysis cassette.  Aliquots (ca. 0.1 mL) of solution were extracted at predetermined 
intervals, and the concentration of silver was measured by ICP-MS.  The final results 
were obtained from triplicate experiments. 
3.3.16. Investigation of Nanoparticle Stability in Aqueous Solution by Monitoring the 
Changes in Hydrodynamic Diameters of 3b, as Measured by DLS 
In MOPS buffer (50 mM, pH 7.4) or ammonium acetate buffer (50 mM, pH 5.0) 
in a vial, 2b was dissolved (0.5 mg/mL).  The prepared solution was incubated in a 
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shaker at 37 °C, and hydrodynamic diameter and ζ-potential were monitored by using 
DLS and ζ-potential, respectively, over time. 
3.3.17. Preparation and Identification of the Degradation Products of 3b 
A solution of 2b (9.2 mg) in 2 mL of nanopure water was incubated in a shaker 
at 37 °C until the micelles were not detectable by DLS.  The solution was lyophilized 
into a powder, and then analyzed by ESI MS, MALDI-TOF MS, and 
31
P NMR 
spectroscopy. 
3.3.18. Study of Enzymatic Degradation of PLLA Block Segment of 3b Using 
Proteinase K (PK) and Porcine Liver Esterase (PLE) 
The enzymatic degradation experiments was performed following our previous 
report.
107
  A solution of 2b (0.5 mL, 0.0032 mM, 0.32 mM of LLA) in 0.1 M Tris-HCl 
buffer at pH 7.4, containing 0.05% (w/v) NaN3, was placed in 1.5 mL centrifugation 
tubes.  Two stock solutions of PLE and PK were also prepared in 0.1 M Tris-HCl buffer 
at pH 7.4, containing 0.05% (w/v) NaN3, to maintain similar enzymatic activities (ca. 1 
U/µL).  The solution of PLE (91 µL, 5,482 U/mL) was diluted in 409 µL of Tris-HCl 
buffer and the solution of PK (367 µL, 1,362 U/mL) was diluted in 133 µL of Tris-HCl 
buffer.  For the enzyme-catalyzed hydrolysis of nanoparticles, stock solutions of enzyme 
(50 µL, 1 U/ µL) were added to each tube, mixed by the use of a vortex, and incubated at 
37 °C, using an incubating shaker.  As a control, to determine the hydrolytic degradation 
rates of the PLLA block segment of the samples in the absence of enzyme catalysis, 50 
µL of Tris-HCl buffer was added to each solution (to maintain identical polymer 
concentrations as the enzyme catalyzed experiment) and incubated at 37 °C in a shaker.  
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The lactate assays were performed following the standard protocol of ab65331 as 
described below.  At time points 0, 1, 6, 12, and 24 h, 50 µL of sample was withdrawn 
from each tube, mixed with 50 µL of lactate enzyme assay mix in a 100 µL Falcon clear 
well, protected from light and incubated at room temperature for 30 min to produce 
color, and analyzed using a plate reader for absorption at 450 nm.  Each analysis was 
performed in triplicate, and average absorbance values with standard deviations were 
reported.  A calibration curve of L-lactic acid was constructed by the use of serial 
dilutions that were produced from a standard solution of 0.1 M L-lactic acid in 0.1 M 
Tris-HCl buffer (calibration range: 0–10 nmol of lactate), and the production of L-lactic 
acid at each time point was quantified and reported as a percentage of the total 
theoretical L-lactic acid present in each solution at the predetermined concentrations. 
3.3.19. Antibacterial Activity 
Minimum inhibitory concentration (MIC) was determined by microdilution in 
Mueller-Hinton (MH) broth.  Briefly, strains were streaked from glycerol stocks onto 
tryptic soy agar plates and grown overnight at 37 °C.  In the following morning, colonies 
were suspended in MH media until OD650 nm = 0.2, and then incubated with shaking at 
37°C until OD650 nm = 0.4 (~5 × 10
8
 colony-forming units [CFU]/mL).  Bacterial strains 
were then diluted to 2 × 10
5 
CFU/mL in MH media and finally diluted 1:1 with 
compounds. 
Silver-compounds were resuspended fresh on the day of the experiment in sterile 
water to a working concentration of 200 µg/mL silver.  Each compound was then diluted 
in MH media to a dose between 0.5 and 12 µg/mL and diluted 1:1 with bacteria.  Plates 
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were incubated statically overnight at 37 °C in the dark and read visually on the next 
day.  The MIC was recorded as the lowest silver dose that did not permit bacterial 
growth. 
Each compound was tested in duplicate or triplicate wells of a 96–well plate and 
repeated on 3–6 separate days.  Results included 1–2 separate batches of compounds for 
a total of 9–15 trials of each compound with each bacterial strain.  Naked 3, i.e., 3 
without silver-loading, was also examined, and the sample did not display any inhibitory 
activity within the ranges tested. 
3.4.  Conclusions 
 In conclusion, fully degradable and functional polymeric nanoparticles as 
delivery carriers for silver-based antimicrobials were developed, and their in vitro 
antimicrobial efficacy and degradability were investigated.  A series of nanoparticles, 
composed of amphiphilic diblock copolymers of phosphoester and L-lactide with 
varying hydrophilic chain lengths, were designed and prepared as potential delivery 
carriers for three different types of silver-based antimicrobials.  While there was no 
evidence of an influence of hydrophilic chain length or loading site on the silver-loading 
capacity of dNPs, optimization of the feed ratio was critical to maximizing the silver 
loading capacity.  The fast release kinetics of Ag-dNPs, typically found in the use of 
micelles, could be beneficial for treatment of infectious diseases, e.g., lung infections via 
pulmonary inhalation administration or urinary tract infections via direct inoculation of 
therapeutics.  The dNP-based antimicrobial delivery system exhibited significant 
improvement in in vitro antimicrobial activity over the parent silver compounds, 
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particularly with reference to the silver carbene cargo.  Finally, the degradability of these 
NPs was demonstrated in comprehensive degradation studies, including the stability of 
dNPs by DLS measurement, identification of the degradation products by ESI MS, and 
electrostatic interaction-mediated enzymatic degradation of dNPs by lactate essays.  
Further studies will develop a better understanding of the fundamental interactions 
between bacterial cells, the dNPs and their degradation products.  Moreover, conjugation 
of the dNPs with tissue-specific targeting proteins or peptides and determination of in 
vivo biodistribution, toxicity, and therapeutic efficacy of the Ag-dNPs against bacterial 
infectious diseases represent important future goals in demonstrating the translational 
potential of these novel nanoconstructs. 
 84 
 
CHAPTER IV  
DEVELOPMENT OF A VINYL ETHER-FUNCTIONALIZED 
POLYPHOSPHOESTER AS A TEMPLATE FOR MULTIPLE 
POSTPOLYMERIZATION CONJUGATION CHEMISTRIES AND STUDY OF 
CORE DEGRADABLE POLYMERIC NANOPARTICLES*
2
 
 
 
4.1. Introduction 
Although ring-opening polymerizations (ROPs) provide a method to transform 
cyclic monomers into well-defined, functional, and degradable polymers,
36,60,90
 it has 
been challenging, in general, with some exceptions,
111,112
 to overcome difficulties that 
are often experienced in the attempt to introduce functional moieties within the cyclic 
monomer structures and with incompatibilities of these desired functionalities during the 
polymerizations.  Alternatively, “click” chemistries such as azide–alkyne Huisgen 
cycloaddition,
113
 Diels–Alder reaction,114 and radical-mediated thiol–ene/yne 
reactions
62,115
 have revolutionized polymer chemistry, allowing for efficient and reliable 
routes toward postpolymerization modifications in the design of complex and functional 
polymeric materials.
116-119
 
                                                 
*
Part of this work is reprinted with permission from “Development of a Vinyl Ether-
Functionalized Polyphosphoester as a Template for Multiple Postpolymerization 
Conjugation Chemistries and Study of Core Degradable Polymeric Nanoparticles” by 
Lim, Y. H., Heo, G. S., Rezenom, H. Y., Pollack, S., Raymond, J. E., Elsabahy, M., and 
Wooley, K. L., 2014, Macromolecules, 47(14), 4634–4644. Copyright [2014] by the 
American Chemical Society. 
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Combined with the extraordinary efficiency in the generation of stable covalent 
linkages by “click”-type reactions in biomaterials,120 acid-labile functionalities, such as 
acetals,
121-123
 ortho esters,
124,125
 and hydrazones,
126,127
 are also of major interest in 
contemporary materials design, especially toward biomedical applications.
128
  In spite of 
the wide utilization of acetals/thio-acetals in synthetic organic chemistry (e.g. as 
hydroxyl protecting groups), they have received less attention in polymer chemistry.  
The most intriguing characteristic of acetal/thio–acetal functionalities originates from 
their unique property of behaving as a “dynamic covalent bond”, i.e. being cleavable 
upon exposure to acidic conditions such as those found in the gastrointestinal tract, 
tissue at sites of inflammation and in tumors, and in endosomal and lysosomal 
compartments,
129-131
 while being relatively stable at the normal physiological 
pH.
122,123,132-134
  In this context, acetals/thio–acetals are appealing for their incorporation 
into biomacromolecules, where the dynamic covalent linkages can bridge to biologically 
active molecules and, ultimately, release them at a targeted site in a controlled manner.  
Furthermore, introduction of hydroxyl functionalities by controlled cleavage of 
acetals/thio–acetals would improve the hydrophilicity of a given polymer, which has 
been limited conventionally due to their incompatibility with the polymerization 
processes.
135
 
The inherent acid-labile property of acetals has been introduced to the backbone 
or the side chains of functional polymers or cross-linkers in the preparation of cross-
linked nanoparticles.  For instance, among several elegant works, reports on acetal-
linked linear polymers or dendrimers have elucidated the cleavability as well as the 
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chemical stability of acetal linkages in a broad spectrum of polymeric systems, e.g., 
degradable, biocompatible dextrans, by Frechet et al.;
121-123,132,134
 poly(ethylene oxides) 
connected with cleavable acetals by Hawker et al.;
136
 hydroxyl-group protection during 
anionic polymerization and hyperbranched polyethers with acetal backbone linkages by 
Frey et al.;
135,137
 acetal-based degradable shell cross-linked polymeric micelles by 
Wooley et al.;
138
 introduction of vinyl ether side chain moieties along poly(ethylene 
glycol) backbones by Wurm et al.
139
 and Brocchini et al.;
140
 and acetal-linked backbone-
cleavable ABA-type triblock copolymers by Ni et al.
141
  Here, our interest is the 
application of acid-labile acetal/thio–acetal linkages to the side chains in degradable 
polymeric systems for their potential use as drug delivery carriers.  Recently, acetal-
linked prodrug micellar nanoparticles and their pH-triggered controlled drug release 
from the side chains have been highlighted by Zhang et al.
142
 and Zhong et al.
143
  
However, the polymeric nanoconstructs used in these studies were hydrocarbon-based, 
nondegradable backbone systems – polymethacrylates and poly(acrylic acid), 
respectively – which limit their application as potential biomaterials because of the 
possible long-term accumulation in the human body. 
A major effort of our group has been to develop polyphosphoesters (PPEs) 
tailored by manipulation of pendant functional groups on the pentavalent phosphorus 
atoms and to integrate the PPE system into new classes of degradable, biocompatible 
polymeric nanomaterials.
39,94,96,98,144
  Particularly, introduction of reactive vinyl ether 
moieties to degradable, biocompatible PPEs
58
 and their utilization to conjugate a library 
of hydroxyl- or thiol-containing biologically active molecules via multiple types of 
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conjugation chemistries are envisioned to expand the breadth of this chemical approach 
in the development of functional biomaterials.  
Herein, we report the organocatalyzed ROP of ethylene glycol vinyl ether-
containing cyclic phosphotriester monomer, as an initial fundamental study toward 
unique degradable, functional polymer materials.  After demonstrating the well-
controlled homopolymerization of the monomer with predetermined molecular weights 
and narrow molecular weight distributions, the resulting vinyl ether-functionalized PPE 
scaffold was conjugated with hydroxyl- or thiol-containing model small molecules via 
three different types of conjugation chemistries – thiol–ene “click” reaction, 
acetalization, or thio–acetalization reaction – revealing efficient routes for 
postpolymerization modifications of functional polymers.  Furthermore, amphiphilic 
diblock copolymers containing the ethylene glycol vinyl ether-functionalized PPE as a 
hydrophobic block segment, also prepared by ROP, afforded well-defined micelles that 
showed a pH-dependent hydrolytic core degradability of both backbone and side chains 
in aqueous solutions.  The degradation products, as identified by mass spectrometry, 
were found to be nontoxic toward two standard cell lines: RAW 264.7 mouse 
macrophages and OVCAR-3 human ovarian adenocarcinoma cells.  Hence, this 
polymeric system can have potential applications in the development of nanomedical 
devices for a variety of biomedical applications. 
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4.2.  Results and Discussions 
4.2.1. Monomer Design and Synthesis 
A novel ethylene glycol vinyl ether-functionalized cyclic phosphotriester 
monomer, 2-ethylene glycol vinyl ether-1,3,2-dioxaphospholane 2-oxide (EVEP), 1, was 
synthesized by following a typical condensation method:  coupling of ethylene glycol 
vinyl ether (EVE) to 2-chloro-3-oxo-1,3,2-dioxaphospholane (COP) in the presence of 
triethylamine (TEA) in dichloromethane (DCM) at 4 °C (Figure 4.1.).  It was critical to 
purify the monomer rigorously, by removing the residual starting materials completely, 
because of the potential for undesired dual initiation by residual EVE and the possible 
formation of random/branched (co)polymers by remaining reactive COP during the 
polymerization process.  Multiple purification methods, including silica gel column 
chromatography, (vacuum) distillation, extraction, and precipitation, were attempted, but 
decomposition of the reactive cyclic monomer and/or incomplete removal of the 
impurities were inevitable in all cases.  Therefore, use of an exact stoichiometric 
equivalence of reagents was attempted, and then the purification process was applied for 
removal of the TEA salts by a series of recrystallization in DCM, precipitation in diethyl 
ether, and filtration.  Even though tetrahydrofuran (THF) could be used as a solvent, 
DCM was more efficient for recrystallization of the TEA salts.  The quantitative 
conversion of EVE and COP to 1 was supported by 
1
H, 
13
C, and 
31
P NMR spectroscopy 
(Figure 4.2.).  By 
13
C NMR spectroscopy, the methylene carbon of the hydroxymethyl 
group of EVE resonating as a singlet (
1
H-decoupled) at 61.2 ppm disappeared upon 
coupling to COP to result in a doublet (J(
31
P,
13
C)) having a coupling constant of 10.2 Hz 
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at 66.1 ppm for the methylene carbon of the new phosphoester linkage.  In addition, 
consumption of the COP was observed by 
31
P NMR spectroscopy as replacement of the 
COP phosphorus resonance at 23.20 ppm with that for the monomer at 17.91 ppm.  
Although the conversion to monomer appeared to be complete, 
1
H NMR analysis 
indicated that there were residual solvents and TEA salts that were not removed (~ 96% 
purity).  However, those impurities did not impact the polymerization. 
 
 
Figure 4.1.  Synthetic route for the preparation of ethylene glycol vinyl ether-
functionalized cyclic phosphotriester monomer 1 and homopolymer 2 by ROP followed 
by postpolymerization modifications via three different types of conjugation chemistries: 
Thiol-ene “click” reaction, acetalization, or thio-acetalization reaction.  
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Figure 4.2.  
1
H (300 MHz, CDCl3, ppm) and 
31
P (121 MHz, CDCl3, ppm, inset) NMR 
spectra of 1. 
 
4.2.2. Homopolymerization of the Monomer 1 by Using an Organocatalyst, DBU 
The ROP of 1 was performed in a glovebox at ambient temperature.  For the 
kinetic study, 1 and benzyl alcohol (BnOH) (molar ratio of 100:1) were mixed in DCM, 
and the polymerization began with the addition of 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU) (molar ratio to initiator of 3:1).  After being stirred for a predetermined period of 
time, an aliquot of the reaction mixture was collected, immediately quenched by adding 
a solution of excess benzoic acid in DCM, and then analyzed by 
31
P NMR spectroscopy.  
A portion of the collected samples was precipitated into diethyl ether prior to injection 
into the gel permeation chromatography (GPC) instrument (Figure 4.3.).  Although 
 91 
 
routine decoupled 
31
P NMR spectroscopy has complications that may limit the 
quantitative value, the distinct resonance frequencies of the phosphorus nuclei of the 
monomer vs. the polymer provided the best opportunity (relative to 
1
H or 
13
C NMR 
spectroscopy) to monitor the polymerization.  Therefore, the conversion was estimated 
from 
31
P NMR spectroscopy by comparing the integral ratio of two distinct peaks of 
monomer 1 at 17.91 ppm and homopolymer, PEVEP, at –0.68 ppm, on crude 
polymerization aliquots.  Once the polymerization was quenched and workeup, 
1
H NMR 
spectroscopy end-group analysis of the degree of polymerization was found to be in 
agreement with the monomer conversion calculated from the 
31
P NMR data.  Both the 
molecular weight and its distribution were determined by GPC.  The kinetic study 
displayed a rapid initial polymerization rate, in which the monomer conversion reached 
at 23% within the beginning 3 min.  However, the maintenance of linearity of Mn vs. 
monomer conversion suggested a living ROP up to 79% conversion (Figure 4.3. (b)).  
The consistent low PDIs (≤1.04) until the monomer conversion reached at 79% indicated 
that there was minimal adverse transesterification of the PPE backbone during the 
polymerization process.  A kinetic plot of ln([M]0/[M]) vs. polymerization time 
illustrated pseudo-first-order kinetics (Figure 4.3. (a)), which is a typical characteristic of 
ROP.   
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Figure 4.3.  (a) Kinetic plots of ln([M]0/[M]) vs. polymerization time (min), obtained 
from 
31
P NMR spectroscopy data.  (b) Kinetic plots of Mn and Mw/Mn vs. monomer 
conversion in ROP of 1, obtained from GPC analysis.  (c) GPC traces as a function of 
elution time (min), after work-up of aliquots of the polymerization mixture by quenching 
with a solution of excess of benzoic acid in DCM and precipitation into diethyl ether.  
Conditions: [EVEP] = 5.2 M in DCM, [EVEP]:[BnOH]:[DBU] = 100:1:3. 
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The same molar ratio used for the kinetic study was applied for a scaled-up 
production of 2.  The purification of 2 by precipitation in diethyl ether was insufficient 
to remove the residual starting materials and benzoic acid completely.  Silica gel column 
chromatography was also attempted, but instability of the PPE backbone was 
problematic.  Dialysis (MWCO 6–8 kDa) of the reaction mixture against organic 
solvents, switching from MeOH to DCM, was the most assured purification method 
among those tested.  Dialysis in basic aqueous solutions (e.g. carbonate buffer at pH 7–
8) was also feasible, but the complete removal of water was challenging, which is 
imperative for the following post-polymerization modification reactions.  Being 
consistent with the kinetic study, quenching the polymerization at a predetermined time 
(9 min), targeting at 50% conversion, yielded the predicted molecular weight and PDI.  
The degree of polymerization (DPn) calculated based on 
31
P NMR spectroscopy-
determined monomer conversion was in agreement with that calculated from chain-end 
analysis by 
1
H NMR spectroscopy, i.e., by comparisons of the integrals of proton 
resonances of the benzyl group (7.43–7.34 or 5.08 ppm, labeled as a or b, respectively, 
in Figure 4.4.(a)) of the initiated chain end to those of the distinct double bonds (6.49 or 
4.06 ppm, labeled as f or g
2, respectively, in Figure 4.4.(a)) or β protons on the 
substituents to the phosphorus atom (3.94–3.86 ppm, labeled as e in Figure 4.4.(a)) of 2, 
which was indicative of retention of the vinyl groups (Figure 4.4.(a)).  In addition, one 
distinct 
31
P resonance confirmed the stability of the degradable PPE backbone during 
ROP of 1 and the work-up process of 2.  GPC analysis of 2 showed a monomodal peak 
with PDI of 1.05. 
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Figure 4.4.  
1
H (300 MHz, CD2Cl2, ppm) and 
31
P (121 MHz, CD2Cl2, ppm, inset) NMR 
spectra of (a) 2, (b) 3, (c) 4, and (d) 5. 
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4.2.3. Thiol-ene “Click” Reaction of the Vinyl Ether Side Chain Moieties of 
PEVEP50 2 with 2-(2-Methoxyethoxy)ethanethiol 
The vinyl ether side chain moieties of 2 were functionalized by thiol–ene “click” 
reaction with thiol-containing model small molecule, 2-(2-methoxyethoxy)ethanethiol.  
The radical-mediated thiol–ene “click” chemistry is a robust and versatile method that 
tolerates a variety of functional groups in achieving a high degree of functionalization on 
vinyl groups.
62,115
  Herein, this efficient chemistry was applied to demonstrate the 
presence and chemical availability of vinyl groups on 2.  To verify the integrity of the 
PPE backbone in the presence of radicals during UV irradiation, a mixture of 2 and 2,2-
dimethoxy-2-phenylacetophenone (DMPA) in methanol-d4 (MeOD4) was irradiated 
under UV light (365 nm, 6 W) for several hours, as a preliminary control reaction.  
31
P 
NMR spectroscopy confirmed that the polymer backbone was intact under these 
conditions.  Accordingly, an excess of 2-(2-methoxyethoxy)ethanethiol relative to the 
vinyl ether bonds was employed with DMPA in MeOH and UV irradiation for 1 h to 
ensure a high coupling efficiency and to avoid undesired cross-linking reactions between 
the double bonds along the backbone.  The purified products were obtained by 
conducting precipitation in diethyl ether followed by sequential dialysis (MWCO 6–8 
kDa) against MeOH and DCM.  Comparison of the 
1
H NMR spectra of 1 and 2 before 
and after thiol–ene “click” reaction, as shown in Figure 4.4. (a) and (b), respectively, 
verified the disappearance of the vinyl proton resonance (6.49 ppm, labeled as f in 
Figure 4.4.(a)) and the corresponding appearance of two distinct proton resonances of 
methoxy (3.33 ppm, labeled as f in Figure 4.4.(b)) and α-protons adjacent to the sulfur 
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atom (2.78–2.69 ppm, labeled as g1 and g2 in Figure 4.4.(b)) in the thio–ether functional 
group.  GPC analysis of 3 clearly showed a peak shift to shorter elution time, relative to 
2, with a monomodal peak having a PDI of 1.07 after thiol–ene “click” reaction (Figure 
4.5.). 
 
 
Figure 4.5.  GPC traces of 2 and 3, before and after thiol-ene “click” reaction, 
respectively, as a function of elution time (min). 
 
4.2.4.  Acetalization of the Vinyl Ether Side Chain Moieties of PEVEP50 2 with 4-
Methylbenzyl Alcohol 
Using commercially-available 4-methylbenzyl alcohol and a catalytic amount of 
p-toluenesulfonic acid (PTSA), the presence and chemical availability of vinyl ether 
moieties of 2 were demonstrated via acetalization.  Initially, to confirm the integrity of 
the PPE backbone in the presence of alcohols and strong acidic catalyst, PTSA (pKa ~ –
2.8 (water)), a mixture of 2 and 2 equiv. of 4-methylbenzyl alcohol (relative to the 
absolute number of vinyl ether bonds) or that of 2 and 0.2 equiv. of PTSA (in relation to 
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the absolute number of vinyl ether bonds) or that of 2, 4-methylbenzyl alcohol. and 
PTSA in N,N-dimethylformamide-d7 (DMF-d7) was allowed to stir for a period of time, 
as a preliminary control reaction.  An aliquot of each reaction solution was collected at a 
predetermined time, quenched by the addition of an excess of TEA, and then evaluated 
by 
31
P NMR spectroscopy.  
31
P NMR spectra confirmed the intact PPE backbone in the 
presence of either 4-methylbenzyl alcohol or PTSA for several hours.  However, the 
combination of 2, 4-methylbenzyl alcohol, and PTSA in the mixture solution was 
accompanied by undesired degradation/transesterification along the PPE backbone 
structure after 6 min of reaction, as confirmed by 
31
P NMR spectroscopy.  Accordingly, 
a scaled-up production of 4 was conducted using the same molar ratio as used for the 
preliminary control reaction, and the acetalization reaction was quenched at 5 min by the 
addition of an excess of TEA to ensure the intact PPE backbone structure.  With respect 
to the purification, Hawker et al. employed an extraction method to purify their acetal-
linked linear poly(ethylene glycol) by using water;
136
 however, this extraction method 
was not compatible with the instability of the PPE backbone in our system.  In addition, 
the complete removal of PTSA and/or 4-methylbenzyl alcohol was not achieved by 
precipitation of the desired polymer in organic solvent, such as diethyl ether.  More 
importantly, this precipitation method was not desirable, especially for acetal-bearing 
polymers as a result of the possible cross-linking side reactions by trans-acetalization in 
the presence of a trace amount of PTSA.
139
  Thus, sequential dialysis (MWCO 6–8 kDa) 
against two different organic solvents, DMF and DCM, was conducted for purification.  
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Finally, the desired product, 4, was obtained after removal of the organic solvents, as 
confirmed by 
1
H and 
31
P NMR spectroscopy (Figure 4.4.(c)).   
The conversion percentage of vinyl ethers to acetals was calculated from chain-
end group analysis by 
1
H NMR spectroscopy, i.e., by comparison of the integrals of 
proton resonances of the benzyl group (7.44–7.32 ppm, labeled as a in Figure 4.4.(c)) of 
the initiated chain end to those of two distinct acetal linkages, methyl (1.33 ppm, labeled 
as j in Figure 4.4.(c)) and methylene (4.87–4.75 ppm, labeled as i in Figure 4.4.(c)), or 4-
methyl protons on the benzyl substituents (2.32 ppm, labeled as m in Figure 4.4.(c)).  
According to the chain-end analysis by 
1
H NMR spectroscopy, approximately 18% of 
the initial vinyl ether groups were converted into the acetal linkages, ca. 50% remained 
intact, and ca. 32% of the repeat units carried hydroxyl groups as a result of hydrolysis.  
The hydrolysis side reaction was probably attributed to a trace of water present in PTSA 
and/or highly viscous PPE.  It is noteworthy that the complete disappearance of vinyl 
proton resonances was observed with prolonged reaction time (1–2 h), which could have 
enhanced the acetal conversion percentage.  However, quenching the reaction at the 
optimal time, 5 min according to the preliminary reaction, was essential for the integrity 
of the PPE backbone.  This backbone stability was verified by the existence of one 
distinct 
31
P resonance peak at –0.68 ppm, observed by 31P NMR spectroscopy.  GPC 
analysis of 4 was not available in THF because of its polar nature, conferred by the 
newly formed hydroxyl groups on the side chains.   
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4.2.5.  Thio-acetalization of the Vinyl Ether Side Chain Moieties of PEVEP50 2 with 
4-Methylbenzyl Mercaptan 
The same reaction protocol for the acetalization reaction was applied to the thio–
acetalization of 2.  The 
1
H NMR spectrum of thio–acetal-bearing PEVEP50, 5, is shown 
in Figure 4.4.(d).  The conversion percentage of vinyl ethers to thio–acetals was 
calculated from chain-end group analysis by 
1
H NMR spectroscopy, i.e., by comparisons 
of the integrals of proton resonances of the benzyl group (7.44–7.32 ppm, labeled as a in 
Figure 4.4.(d)) of the initiated chain end to those of the two distinct thio-acetal linkages, 
methyl (1.51 ppm, labeled as j in Figure 4.4.(d)), methylene (4.71 ppm, labeled as i in 
Figure 4.4.(d)) or 4-methylbenzyl protons (2.31 ppm, labeled as m in Figure 4.4.(d)).  By 
1
H NMR chain-end analysis, approximately 8% of the initial vinyl groups were found to 
be converted into the thio-acetal linkages, ca. 56% of them remained intact, and ca. 36% 
of the repeat units underwent hydrolysis of the side chains to present hydroxyl groups.  
The intact PPE backbone was affirmed by the presence of one distinct 
31
P resonance 
peak at -0.67 ppm, as measured by 
31
P NMR spectroscopy.  Similar to the acetal linkage-
bearing polymer, 4, the polar nature endowed by the newly formed hydroxyl groups on 
the side chains did not allow for GPC analysis. 
4.2.6. Synthesis of the Amphiphilic Diblock Copolymer, α-Methoxy Poly(ethylene 
glycol)44-block-poly(ethylene glycol vinyl ether phosphotriester)33 (mPEG44-b-
PEVEP33), 6 
Based on the kinetic study of 2, amphiphilic diblock copolymer, mPEG44-b-
PEVEP33, 6, was prepared by ROP using the molar ratio 100:1:3 of 1, α-methoxy-ω-
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hydroxy poly(ethylene glycol) 2000 Da (mPEG44-OH), and DBU, respectively (Figure 
4.6.).  The polymerization was quenched at 6 min by the addition of a solution of excess 
of benzoic acid in DCM, and the desired diblock copolymer product was obtained after 
sequential dialysis (MWCO 6–8 kDa) against organic solvents, MeOH and DCM.  The 
DPn calculated based on 
31
P NMR spectroscopy-determined monomer conversions was 
in agreement with that calculated from chain-end analysis by 
1
H NMR spectroscopy, i.e., 
by comparisons of the integrals of the proton resonance of the methyl group of the 
initiated chain end (3.33 ppm, labeled as a in Figure 4.7.(a)) to that of the double bond 
(6.49 or 4.06 ppm, labeled as f or g
2
, respectively, in Figure 4.7.(a)) or α- protons to the 
vinyl ether oxygen atom (3.94–3.86 ppm, labeled as e in Figure 4.7.(a)) of the PEVEP 
block segment.  Additionally, one distinct 
31
P resonance peak at -0.71 ppm confirmed 
the intact PEVEP block backbone structure during the chain extension by ROP of 1 and 
the work-up process of 6.  GPC analysis of 6 showed a distinct peak shift to lower 
elution time from that of the macroinitiator, mPEG44-OH, after polymerization, with a 
monomodal peak with a PDI of 1.09 (Figure 4.7.(b)). 
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Figure 4.6.  Synthetic route for the preparation of amphiphilic diblock copolymer 6 and 
schematic illustration of the assembly of 6 into micelles 7 by direct dissolution in water 
followed by the hydrolytic core degradation of 7. 
 
 
Figure 4.7.  (a) 
1
H (300 MHz, CD2Cl2, ppm) and 
31
P (121 MHz, CD2Cl2, ppm, inset) 
NMR spectra of 6.  (b) GPC traces of macroinitiator, mPEG44-OH, and diblock 
copolymer 6, mPEG44-b-PEVEP33, as a function of elution time (min). 
 
4.2.7.  Thermal Properties 
The Tg values of the prepared polymers varied, as measured by differential 
scanning calorimetry (DSC), depending on the side chain substituents (Table 4.1.).  The 
conjugation of the 2-(2-methoxyethoxy)ethanethioether groups onto the side chains 
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induced a decrease of the Tg value from –39 °C of 2 to –64 °C of 3 after the thiol–ene 
“click” reaction.  The slight increase of Tg value of 4 and 5, –27 and –31 °C, 
respectively, as compared with that of 2, –39 °C, was ascribed to the rigidity and π–π 
interactions of the aromatic rings.  Meanwhile, the Tg value of the diblock copolymer 
with the extended ethylene glycol backbone units, 6, was complicated to analyze but 
appeared to give only a single Tg value, similar to that of 2, –38 °C.  In addition, no Tm 
for the PEG block segment was observed for the diblock system, therefore, an extensive 
investigation against the homopolymers, mPEG44-OH and PEVEP50, and a mPEG44-
OH/PEVEP50 blend was conducted.  These studies confirmed that the PEVEP block 
fully suppresses PEG crystallinity in the diblock system; while the physical blend does 
little to suppress PEG crystallization (full DSC traces for all systems upon heating and 
cooling are presented with detailed discussions in the Supporting Information (Figure 
4.19.)). 
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Table 4.1.  Comparisons of Glass Transition Temperatures, Tg, of the Prepared 
Polymers, As Measured by Differential Scanning Calorimetry (DSC). 
Polymer Tg (°C) 
PEVEP50, 2 –39 
PEVEP50 
after thiol–ene “click” reaction, 3 
–64 
PEVEP50 
after acetalization reaction, 4 
–27 
PEVEP50 
after thio–acetalization reaction, 5 
–31 
mPEG44-b-PEVEP33, 6 –38 
 
4.2.8.  Self-Assembly of the Amphiphilic Diblock Copolymer, mPEG44-b-PEVEP33 6 
 The self-assembly behavior of the amphiphilic diblock copolymer, mPEG44-b-
PEVEP33 6, was studied by direct dissolution in nanopure water.  A high concentration 
of 6 could be dispersed in nanopure water or buffer (>15 mg/mL) without a significant 
turbidity or precipitation, which allowed for analyses to be performed across a broad 
range of concentrations and also serves as a promising criterion for its use as a drug 
delivery carrier.  The morphology and surface charge of the resulting micellar 
nanoparticles, 7, were characterized by dynamic light scattering (DLS), transmission 
electron microscopy (TEM), atomic force microscopy (AFM) and ζ-potential 
measurements (Figure 4.9. and Figure 4.8.).  DLS and ζ-potential analyses indicated 
narrow and monomodal size distributions (PDI = 0.114) with almost neutral charges and 
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a negligible difference at pH 5.0 and 7.4, –4.52 and –7.64 mV, respectively.  The 
number-averaged hydrodynamic diameter of 7 by DLS was ca. 44 ± 6 nm.  The TEM 
images also revealed uniform nanoparticles with an average diameter of 39 ± 5 nm.  
Although the hydrodynamic and dry-state diameters measured by DLS and TEM, 
respectively, were in agreement, AFM indicated significant deformation of the micelles 
upon deposition and drying on the mica substrate.  The ca. 3 nm height and 40 ± 7 nm 
diameter indicate flattening of the micelles, which is predicted to occur based upon the 
fluid shell and core components, each being composed of a highly viscous polymer, PEG 
(Tg = –17 °C) and PEVEP (Tg = –39 °C, Table 4.1. and Figure 4.19.).  The AFM data are 
useful qualitatively; however, further quantitative analysis is complicated by the 
presence of substantial amounts of polymer debris and agglomerations of 7 across the 
substrate (Figure 4.9.(c) and (d)), which are also indicators of the fluidity of the micellar 
assemblies.   
 
 
Figure 4.8.  ζ-Potential values of 7 in acetate buffer solutions at pH 5.0 and in MOPS 
buffer solutions at pH 7.4.  The average values and their standard deviations, from three 
measurements, are shown. 
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Figure 4.9.  Self-assembly results of micelle 7 in water.  (a) DLS results of 7:  Dh(intensity) 
= 49 ± 7 nm, Dh(volume) = 46 ± 7 nm, and Dh(number) = 44 ± 6 nm (PDI = 0.114).  (b) TEM 
image of 7:  Dav = 39 ± 5 nm, after counting more than 150 nanoparticles.  AFM height 
image (c) and three-dimensional image (d) of 7:  Dav = 40 ± 7 nm, after counting more 
than 100 nanoparticles. 
 
4.2.9.  Degradation Study 
The phosphoester linkages of PPEs can be cleaved by spontaneous hydrolysis 
and/or enzymatic degradation; the hydrolysis rate of the phosphoester linkages is known 
to be highly pH-dependent.
42,104,106,145-147
  In this study, we postulated that the exposure 
of micelles, 7, in acidic aqueous environment would induce a dual degradation of the 
phosphoester backbone linkages and the vinyl ether side chain moieties of the PEVEP 
block segment.  Hence, the stability of the phosphoester backbone linkage and the vinyl 
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ether functionality of 7 were monitored in deuterated buffer solutions by 
31
P and 
1
H 
NMR spectroscopies, respectively, in parallel to measuring the micelle size and the 
intensity by DLS.  Furthermore, the collected degradation products were identified using 
electrospray ionization (ESI), gas chromatography (GC), and matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. 
4.2.10. Degradability of the PEVEP Backbone in Aqueous Solutions, As Monitored by 
31
P NMR Spectroscopy 
The backbone stability of the PEVEP segment in D2O at pH values of 5.0 and 7.4 
and temperature of 37 °C was monitored by 
31
P NMR spectroscopy (Figure 4.10.).  The 
integral ratio of the 
31
P resonance of the intact PEVEP segment at –0.71 ppm to that of 
the newly emerging peaks was analyzed.  The pH-dependent degradation of the PEVEP 
backbone linkages became apparent by the disappearance of 
31
P resonance 
corresponding to the intact PEVEP backbone, coincident with the appearance of new 
31
P 
resonances as a result of hydrolytic degradation at pH 5.0, whereas there was no 
significant change in the PEVEP 
31
P resonance when the samples were incubated at pH  
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Figure 4.10.  (a) Rate of the PEVEP backbone degradation of 7 at pH 5.0 (black line) or 
pH 7.4 (red line) at 37 °C as a function of time, as measured by a comparison of the 
integrals of initial to the newly appeared 
31
P NMR resonances.  Changes in the 
31
P NMR 
resonance of PEVEP backbone of 7 at pH 5.0 (b) and 7.4 (c) at 37 °C over a period of 
time. 
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4.2.11. Stability of the Vinyl Ether Side Chain Moieties in Aqueous Solutions, As 
Monitored by 
1
H NMR Spectroscopy 
To compensate for potential complications in the detection of vinylic proton 
resonances of the micelle core, we evaluated the pH-dependent hydrolytic reactivity of 
the vinyl ether functionalities by observing both the polymer side chain functionalities 
and the small molecule hydrolysis product using 
1
H NMR spectroscopy.  To determine 
the reactivity of the acid-labile vinyl ether functionality, the integral ratio of a distinct 
vinyl proton resonance of the micelles at 6.49 ppm to the newly appeared proton 
resonance of acetaldehyde, one of the hydrolysis products of the vinyl ether 
functionality, at 9.60 ppm was compared in D2O at pH values of 5.0 and 7.4 at 37 °C 
over a period of time (Figure 4.11.).  For the micellar nanoparticles in pH 5.0 aqueous 
solution at 37 °C, both the gradual disappearance of vinyl proton resonance intensity and 
the appearance of an acetaldehyde proton resonance signal were clearly observed within 
1 day, and the equal ratio of these two different proton resonances was reached after 14 
days.  By contrast, the vinyl proton resonance of the micelles in pH 7.4 aqueous solution 
at 37 °C remained consistent without any observable generation of acetaldehyde over 39 
days.  Indeed, this observation bolstered our hypothesis that the spontaneous cleavage of 
the vinyl ether moieties occurred in pH 5.0 aqueous solution simultaneously with the 
PPE backbone degradation, but not at pH 7.4.  
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Figure 4.11.  Rate of formation of acetaldehyde or disappearance of vinyl proton 
resonance at pH 5.0 (a) and pH 7.4 (b) and at 37 °C as a function of time, as measured 
by a comparison of the integrals of vinyl and acetaldehyde proton resonance.  Transition 
of proton resonances of acetaldehyde and vinyl groups at pH 5.0 (c) or pH 7.4 (d) and at 
37 °C over a period of time. 
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4.2.12. Hydrolytic Micelle Stability in Water by Monitoring the Changes in (1) 
Hydrodynamic Diameter and (2) the Intensity of Light, Scattered by Micelles 7, As 
Measured by DLS 
It was hypothesized that hydrolysis of the PPE backbone would decrease the 
proportion of the hydrophobic:hydrophilic block segment ratio and that hydrolysis of the 
side chain vinyl ether groups would increase the hydrophilicity of the PPE backbone; 
thereby, each would weaken the micelle assemblies.  In order to demonstrate the effects 
of pH-dependent hydrolytic degradation of the polymer on the behavior and stability of 
the micelles, 7, aqueous buffer solutions containing 6 at pH 5.0 and 7.4 were incubated 
at 25 and 37 °C, and their degradation profiles were assessed by measuring the changes 
in hydrodynamic diameter and the intensity of light, scattered by micelles, when 
measured by DLS over a period of time (Figure 4.12.).  Overall, as predicted from the 
NMR degradation studies, the micelle assemblies in pH 5.0 aqueous solutions, at both 25 
and 37 °C, became unstable within 1 day, and the nanoparticles were undetectable within 
7 and 2 days, respectively.  The swelling behavior of the micelles upon hydrolysis of 
PEVEP segment was accounted for by the diffusion of water into the core region (Figure 
4.12.(a)).  Interestingly, the unstable and dissociated micelles did not cause the 
formation of visible precipitates, and thus, the micelle solutions remained clear during 
monitoring.  Also, in agreement with the lack of backbone or side chain hydrolysis 
observed by NMR spectroscopy, the nanoparticle sizes in pH 7.4 aqueous solutions at 25 
°C remained consistent over 39 days (Figure 4.12.(b)).  Surprisingly, when the samples 
were incubated at pH 7.4 and 37 °C, large aggregates formed after 20 days, which 
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persisted until day 43 when particles were no longer detectable.  The lack of changes in 
the NMR data over the same period of time and conditions suggests that 
transesterification reactions may be a possible chemical change that produced 
subsequent morphological changes.  In accordance with these observations, the intensity 
of light, scattered by the nanoparticles, as measured by DLS, was also dependent on the 
pH of water and temperature (Figure 4.12.(c)).  In the case of nanoparticles in pH 5.0 
aqueous solutions, both at 25 and 37 °C, the signal intensities became weaker rapidly, 
reaching below 20% as compared to the initial intensity, and finally were undetectable 
within a week.  The signal intensity of light scattered by micelles in pH 7.4 aqueous 
solution at 37 °C decreased gradually over a period of month.  Meanwhile, there was no 
significant change in the signal intensity for the micelles in pH 7.4 aqueous solution at 
25 °C throughout the monitoring period.  Taken together, the acidity of solutions was the 
primary determinant of the micelle stability.  
 112 
 
 
Figure 4.12.  Study of the micelle stability by using DLS.  Changes in the hydrodynamic 
diameter of micelles at pH 5.0 (a) or pH 7.4 (b) and at a temperature of 25 °C (black 
line) or 37 °C (red line) over a period of time.  (c) Changes in the relative intensity of 
micelles in different environments, pH and temperature, over a period of time.  The 
average values and their standard deviations, from three measurements, are shown. 
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4.2.13. Identification of the Degradation Products by ESI, GC and MALDI-TOF Mass 
Spectrometry 
There have been several reports where the hydrolytic or enzymatic degradation 
behavior of PPE-containing micelles were studied by using titration,
104
 NMR 
spectroscopy,
42,104
 GPC,
106,145-147
 and/or DLS
144
 methods;  however, to the best of our 
knowledge, the identification of the actual degradation products of PPE has not been 
performed directly.  In this study, we successfully identified the degradation products of 
PPE qualitatively using electrospray ionization (ESI), gas chromatography (GC), and 
matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry.  For this study, nanoparticles in aqueous solution at pH 5.0 were incubated 
at 37 °C until they were not detectable by DLS, and the complete disappearance of 
31
P 
resonance signal from the intact PEVEP backbone was confirmed by 
31
P NMR 
spectroscopy.  The mixture solution containing the degradation products was analyzed 
by using ESI, GC, and MALDI-TOF MS.   
The presence of oligomers and phosphoric acids was confirmed by ESI MS 
(Figure 4.13.), demonstrating the hydrolytic degradability of phosphoester linkages of 
PPE.  Tandem mass spectrometry was performed on most of the precursor ions as a way 
of verifying the chemical structures of these ions.  The MS/MS product ions are listed 
along with the structures in Figure 4.13.   
Two series of oligomers (f and g series) that differ by 44 Da were observed 
(Figure 4.13.).  In order to verify that the f series were not the fragments of the g series, 
i.e., by losing vinyl alcohol (m/z 44), MS/MS of the lower mass precursor ions m/z 309 
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and 353 were performed (Figure 4.14. and 4.15.).  The predominant fragment ion for m/z 
309 was 141 while that for m/z 353 was 185, thus both losing a neutral repeating unit, 
168.  In addition, a loss of ethylene glycol was observed for both ions.  However, unlike 
the precursor ion m/z 353, m/z 309 lost vinyl dihydrogen phosphate to produce ion e.  
This major difference implied that the end group of the f series oligomers is 2-
hydroxyethyl dihydrogen phosphate, while that of g series oligomers is bis(2-
hydroxyethyl) hydrogen phosphate.  Therefore, the f series were not the fragment ions 
from the g series. 
Because of its unionizable nature by electrospray ionization, the presence of 
ethylene glycol, as one of the degradation products, was confirmed by GC MS with 
electron ionization (EI) (Figure 4.16.).  Neither vinyl- nor vinyl ether-containing 
compounds were detected using GC MS, which agreed with our observation by 
1
H NMR 
spectroscopy, shown in Figure 4.11.  Again, this absence of vinyl or vinyl ether 
functionalities within the degradation products substantiated our hypothesis of a 
simultaneous hydrolysis of the vinyl ether moieties during the degradation process of the 
PPE backbone.  Finally, MALDI-TOF MS analysis of the mixture of the degradation 
products verified the presence of the intact PEG block segment with a single distribution 
having a spacing of 44 Da, corresponding to a PEG repeat unit (Figure 4.17.). 
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Figure 4.13.  ESI MS analysis of the degradation products of 8.  Mass spectra in negative 
ion mode; m/z range of 100–2000 (a) and 50–180 (b).  See Figures 4.14. and 4.15. for 
MS/MS spectra of f1 and g1. 
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Figure 4.14.  MS/MS spectrum of m/z 309. 
 
 
Figure 4.15.  MS/MS spectrum of m/z 353. 
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Figure 4.16.  GC MS analysis of the degradation products of 8.  (a) Extracted ion 
chromatogram at m/z 62.  (b)  EI MS at retention time 4.74 min.  
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Figure 4.17.  MALDI-TOF MS spectrum of the degradation products of 8. 
 
4.2.14. Cytotoxicity of Micelles of mPEG44-b-PEVEP33 7 and Their Degradation 
Products 8 
The cytotoxicities of the parent micelles, 7, and their degradation products, 8, 
were evaluated toward two cell lines, RAW 264.7 mouse macrophages and OVCAR-3 
human ovarian adenocarcinoma cells at a concentration range from 3 to 3000 µg/mL for 
24 h (Figure 4.18.).  Both 7 and 8 maintained high cell viability over the range of the 
tested concentrations in both cell lines.  We have previously observed low cytotoxicity 
and immunotoxicity of PPE-based micelles with different surface charges, their shell 
cross-linked analogs and their degradation products even though we were not able to 
identify the degradation products at that time.
97
  These PPE-based nanoparticles are 
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expected to have broad implications in clinical nanomedicine as alternative vehicles to 
those involved in several of the currently available medications, with precise control 
over their molecular structures and overall architectures. 
 
 
Figure 4.18.  Cytotoxicity of the parent micelles of mPEG44-b-PEVEP33 7 (black line) 
and their degradation products 8 (red line) at a concentration range of 3–3000 µg/mL for 
24 h in RAW 264.7 mouse macrophages (a) and OVCAR-3 human ovarian 
adenocarcinoma cells (b). 
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4.2.15. Additional Thermal Studies Regarding the Suppression of the Crystallinity of 
PEG in mPEG44-b-PEVEP33 
Since the ability of the PEVEP block segment to suppress the crystallization of 
PEG was unexpected, additional experiments were conducted to confirm the finding by 
contrasting the mPEG44-b-PEVEP33 diblock behavior to two analogous homopolymers, 
mPEG44-OH and PEVEP50, and an equimolar physical blend of mPEG44-OH and 
PEVEP50.  Furthermore, we present these studies in contrast to liquid nitrogen crash-
cooled (CC) samples of mPEG44-OH, mPEG44-b-PEVEP33 and the mPEG44-
OH/PEVEP50 blend (Figure 4.19.), in order to kinetically capture PEG domains in an 
amorphous state and enhance the ability to observe PEG Tg values.  Looking at the Tm 
region for PEG in the mPEG44-b-PEVEP33 and mPEG44-OH/PEVEP50 blend samples, 
for both crash-cooled and ambient-cooled samples, it was clear that (regardless of the 
cooling rate) the PEVEP block completely suppresses the crystallization of PEG for the 
diblock copolymer system and that the blend still expresses a high degree of PEG 
crystallinity.  This result made a strong case for the diblock structure being critical to the 
observed suppression of PEG crystallization, not merely an effect of the presence of 
PEVEP.  When crash-cooled, the mPEG44-OH sample presented Tg at ca. -17 °C, the 
crash-cooled mPEG44-OH/PEVEP50 blend displayed a minor transition in the same 
range, however, the mPEG44-b-PEVEP33 diblock showed an uncertain fluctuation of the 
baseline over the broad range from -20 to +30 °C, which complicated the analysis and 
prevented determination of whether there may be amorphous PEG-rich domains in the 
diblock sample that were capable of exhibiting a glass transition.  Comparison of the 
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PEVEP50, mPEG44-b-PEVEP33 and blend samples over the -40 to -25 °C range indicated 
a virtually identical heat curve for Tg of PEVEP at ca. -35 °C.   
 
 
Figure 4.19.  DSC traces for mPEG44-OH, PEVEP50, mPEG44-b-PEVEP33 and a physical 
mixture of mPEG44-OH and PEVEP50.  The crash-cooling (CC) samples are those which 
were crash-cooled from 100 °C into liquid nitrogen before heating.  (a) Trace over the 
region of interest (-60–60 °C) for the system, offset to increase clarity.  (b) Rescaled 
trace (-50–60 °C) to contrast the glass transition regions for all samples.  
 
4.3.  Experimental Section 
4.3.1.  Materials 
Ethylene glycol vinyl ether (EVE), 2-(2-methoxyethoxy)ethanethiol, 2,2-
dimethoxy-2-phenylacetophenone (DMPA), diethyl ether, triethylamine (TEA), 
methanol (MeOH) and benzoic acid were used as received from Sigma-Aldrich 
Company or TCI America.  2-Chloro-2-oxo-1,3,2-dioxaphospholane (COP) was used as 
received from Thermo Fisher Scientific Inc.  Benzyl alcohol (BnOH), 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU), 4-methylbenzyl alcohol, 4-methylbenzyl 
mercaptan were purchased from Sigma-Aldrich Company, and they were distilled from 
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calcium hydride prior to use.  p-toluenesulfonic acid monohydrate (PTSA) was 
purchased from Sigma-Aldrich Company, and it was dried by azeotropic distillation in 
toluene three times prior to use.  α-Methoxy-ω-hydroxy poly(ethylene glycol) 2,000 Da 
(mPEG44-OH) was purchased from Rapp Polymere, and it was dried by azeotropic 
distillation in toluene three times prior to use.  The dried benzyl alcohol, DBU, 4-
methylbenzyl alcohol, 4-methylbenzyl mercaptan, PTSA and mPEG44-OH were stored 
in an argon-filled glovebox until use.  Dichloromethane (DCM) and N,N-
dimethylformamide (DMF) were dried through columns (J. C. Meyer Solvent Systems, 
Inc.).  Spectra/Pro® membranes (MWCO 6‒8 kDa, Spectrum Medical Industries, Inc., 
Laguna Hills, CA) were used for dialysis.  RAW 264.7 and OVCAR-3 cell lines, as well 
as RPMI and DMEM media were purchased from the American Type Culture 
Collection.  Media additives (fetal bovine serum, penicillin/streptomycin) were 
purchased from Sigma Aldrich Company.  The cell culture 96-well flat bottom plates 
were purchased from Corning Costar Co.  The CellTiter 96 non-radioactive cell 
proliferation assay was obtained from Promega Co. 
4.3.2.  Characterization Methods 
1
H, 
13
C, and 
31
P NMR spectra were recorded on Inova 300 MHz spectrometers 
interfaced to a UNIX computer using VnmrJ software.  Chemical shifts were referenced 
to solvent resonance signals.  For 
31
P NMR spectroscopy, phosphoric acid (85 wt. % in 
H2O) at 0 ppm was used as an external standard.  IR spectra were recorded on an IR 
Prestige 21 system (Shimadzu Corp.) and analyzed by using the IRsolution software. 
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The polymer molecular weight and molecular weight distribution were 
determined by Gel Permeation Chromatography (GPC).  The GPC was conducted on a 
Waters 1515 HPLC (Waters Chromatography, Inc.) equipped with a Waters 2414 
differential refractometer, a PD2020 dual-angle (15° and 90°) light scattering detector 
(Precision Detectors, Inc.), and a three-column series (PL gel 5 µm Mixed C, 500 Å, and 
104 Å, 300 × 7.5 mm columns; Polymer Laboratories, Inc.).  The system was 
equilibrated at 40 °C in THF, which served as the polymer solvent and eluent with a 
flow rate of 1.0 mL/min.  Polymer solutions were prepared at a known concentration (3‒
5 mg/mL) and an injection volume of 200 µL was used.  Data collection and analysis 
were performed with Precision Acquire software and Discovery 32 software (Precision 
Detectors, Inc.), respectively.   
Glass transition temperatures (Tg) were measured by differential scanning 
calorimetry (DSC) on a Mettler-Toledo DSC822® (Mettler-Toledo, Inc., Columbus, 
OH), with a heating rate of 10 °C/min.  Measurements were analyzed by using Mettler-
Toledo Star
e
 v. 7.01 software.  The Tg was taken as the midpoint of the inflection 
tangent, upon the second heating scan.  Thermogravimetric analysis (TGA) was 
performed under N2 atmosphere using a Mettler-Toledo model TGA/SDTA851e, with a 
heating rate of 5 °C/min and cooling rate of 5 °C/min.  Measurements were analyzed by 
using Mettler-Toledo Star
e
 v. 7.01 software.   
Dynamic light scattering (DLS) measurements were conducted using Delsa Nano 
C (Beckman Coulter, Inc., Fullerton, CA) equipped with a laser diode operating at 658 
nm.  Size measurements were made in nanopure water (n = 1.3329, ƞ = 0.890 cP at 25 ± 
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1 °C).  Scattered light was detected at 165° angle and analyzed using a log correlator 
over 70 accumulations for a 3.0 mL sample in a glass sizing cell (4.0 mL capacity).  The 
samples in the glass sizing cell were equilibrated for 30 minutes before measurements 
were made.  The photomultiplier aperture and the attenuator were automatically adjusted 
to obtain a photon counting rate of ca. 10 kcps.  Calculation of the particle size 
distribution and distribution averages was performed using CONTIN particle size 
distribution analysis routines.  The peak averages of histograms from number 
distributions out of 70 accumulations were reported as the average diameters of the 
particles. 
The zeta potential values of the nanoparticles were determined by Delsa Nano C 
particle analyzer (Beckman Coulter, Fullerton, CA) equipped with a 30 mW dual laser 
diode (658 nm).  The zeta potential of the particles in suspension was obtained by 
measuring the electrophoretic movement of charged particles under an applied electric 
field.  Scattered light was detected at a 30° angle at 25 °C.  The zeta potential was 
measured at five regions in the flow cell and a weighted mean was calculated.  These 
five measurements were used to correct for electroosmotic flow that was induced in the 
cell due to the surface charge of the cell wall.  All determinations were repeated three 
times. 
Transmission electron microscopy (TEM) images were collected on a JEOL 
1200EX operating at 100 kV and micrographs were recorded at calibrated 
magnifications using a SIA-15C CCD camera.  The samples as aqueous solutions (5 µL) 
were deposited onto carbon-coated copper grids.  Excess sample was wicked off using 
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filter paper and the grids were allowed to dry in the air for 1 min.  Following this, the 
grids were stained with 5 µL of a 2% uranyl acetate aqueous solution.  Excess stain was 
wicked off by using filter paper after 20 seconds.  The sample grids were dried under 
vacuum overnight before analysis. 
Atomic force microscopy (AFM) imaging was performed by using a MFP-3D 
system (Asylum Research) using a standard silicon probe (VISTAprobes, resonance 
constant: 62 kHz, tip radius: 15 nm, spring constant: 3 N/m).  For AFM sample 
preparation, the sample was dissolved in nanopure water at 0.25 mg/mL and 20 µL of 
the sample was spin coated onto a glass coverslip.  All AFM samples were stored at 
room temperature under vacuum prior to use. 
Electrospray ionization (ESI) in negative ion mode was carried on a quadruple 
ion trap mass spectrometer (LCQ-DECA, ThermoFinnigan, San Jose, CA).  The sample 
was directly infused at a flow rate of 6 µL/min.  The spray voltage was set at -4.5 kV.  
Sheath gas and auxiliary gas flow rates were 50 and 10 arbitrary units, respectively.  
Transfer capillary temperature was held at 250 °C.  MS/MS experiments were performed 
on the same instrument at a relative collision energy of 30−32%.  Xcalibur 2.0 software 
package (ThermoFinnigan) was used for data acquisition and processing. 
Gas chromatography-mass spectrometry (GC-MS) was performed on Ultra 
GC/DSQ (ThermoElectron, Waltham, MA).  Chromatography was carried out using an 
Rxi-5ms column (60 m × 0.25 mm with 0.25 μm film thickness) (Restek; Bellefonte, 
PA).  Helium was used as a carrier gas at constant flow of 1.5 mL/min.  GC inlet was 
held at 225 °C while transfer line and ion source were held at 250 °C.  An aliquot of 1 
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µL of sample was injected in splitless mode.  The oven temperature was maintained at 
50 °C for 5 min and raised to 320 °C at 20 °C/min.  Electron impact ionization at 70eV 
was used for ionization and mass spectra were acquired in full scan mode in the range of 
30-500 m/z.   
Matrix assisted laser desorption ionization (MALDI) experiments were 
performed on a Voyager DE-STR mass spectrometer (Applied Biosystems, Foster City, 
CA) under optimized conditions in positive linear mode.  Ions were generated by a 
pulsed nitrogen laser at 337 nm and accelerated through 25 kV.  100 laser shots were 
used per spectrum. Trans-2-[3-(4-t-butyl-phenyl)-2-methyl-2-propenylidene] 
malononitrile (DCTB) and potassium trifluoroacetate (KTFA) were used as a matrix and 
cationization reagent, respectively.  The sample, KTFA, and matrix were prepared at 
concentration of 1, 10 and 20 mg/mL respectively.  The sample solution was mixed with 
the matrix and KTFA at a volume ratio of 1:5:1.  About 0.5 µL of this mixture was 
deposited on a stainless steel sample holder.  After air-dried, the sample was analyzed 
using MALDI TOF MS. 
4.3.3. Synthesis of Monomer, 2-Ethylene glycol vinyl ether-1,3,2-dioxaphospholane 
2-oxide (EVEP) 
A solution of COP (5.0026 g, 35.11 mmol) in 10 mL of anhydrous DCM was 
added dropwise to a stirred solution of EVE (3.0908 g, 35.08 mmol) and TEA (4.89 mL, 
3.55 g, 35.1 mmol) in 50 mL of anhydrous DCM at 4 °C.  The reaction mixture was 
allowed to stir for 12 h at 4 °C and then for 30 min at rt.  The precipitate was filtered off, 
and the filtrate was concentrated under reduced pressure.  Diethyl ether (200 mL) was 
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then added to precipitate the remaining triethylammonium chloride.  After the removal 
of the precipitates by filtration and the solvent in vacuo, the clear viscous liquid EVEP 
was collected (5.13 g, 76% yield).  IR: 3045–2800, 1622, 1500–1432, 1368, 1285, 1198, 
1070, 1024, 993, 926, 835, 764 cm
-1
.  
1
H NMR (CDCl3, ppm): δ 6.44 (dd, J = 14.4 Hz, J 
= 6.9 Hz, 1H, CH2OCHCH2), 4.46–4.26 (m, 6H, POCH2CH2OP and 
POCH2CH2OCHCH2), 4.16 (dd, J = 14.4 Hz, J = 2.4 Hz, 1H, CH2OCHCHH), 4.01 (dd, 
J = 6.9 Hz, J = 2.4 Hz, 1H, CH2OCHCHH), 3.86 (m, 2H, POCH2CH2OCHCH2).  
13
C 
NMR (CDCl3, ppm): δ 151.3, 87.3, 66.8 (d, J = 23.4 Hz), 66.6 (d, J = 24.3 Hz), 66.1 (d, 
J = 10.2 Hz).  
31
P NMR (CDCl3, ppm): δ 17.91.  +ESI MS: calculated [M+H]
+
 for 
C6H11O5P: 195.0422, found: 195.0419. 
4.3.4. Kinetic Study of the Homopolymerization of EVEP via ROP by Using an 
Organocatalyst, DBU 
In a glovebox, a solution of EVEP (1.0050 g, 5.18 mmol) and benzyl alcohol 
(5.34 µL, 5.58 mg, 0.052 mmol) in anhydrous DCM (1.0 mL) was placed in a flamed-
dried 5 mL shell vial with a magnetic stir bar.  DBU (23.1 µL, 23.5 mg, 0.15 mmol) was 
added into the mixture solution.  70 µL of samples were extracted at 1, 2, 3, 4, 5, 7, 9, 
11, 13, 15, and 18 min and quenched immediately by adding a solution of benzoic acid 
(excess).  Conversion of monomer to polymer was calculated by 
31
P NMR spectroscopy.  
A portion of the collected samples was purified by precipitation in diethyl ether twice 
and dried in vacuo before injection into the THF GPC to obtain the number average 
molecular weight, Mn, and polydispersity index, PDI. 
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4.3.5. Synthesis of Homopolymer, Poly(ethylene glycol vinyl ether phosphotriester)50 
(PEVEP50) 
In a glovebox, a solution of EVEP (1.9991 g, 10.30 mmol) and benzyl alcohol 
(10.7 µL, 11.2 mg, 0.10 mmol) in anhydrous DCM (2.0 mL) was placed in a flamed-
dried 5 mL shell vial with a magnetic stir bar.  DBU (46.2 µL, 47.0 mg, 0.31 mmol) was 
added into the mixture solution.  After 9 min of stirring, the reaction was quenched 
immediately by adding a solution of benzoic acid (excess).  The product was dialyzed 
(MWCO 6–8 kDa) in MeOH followed by DCM overnight.  A viscous liquid was 
collected after removal of the solvent in vacuo (0.5588 g, 56% yield).  GPC (THF): Mn = 
4040 g/mol, PDI = 1.05.  IR: 3700–3300, 3025–2825, 1622, 1454, 1425–1350, 1323, 
1269, 1198, 1022, 964, 812 cm
-1
.  
1
H NMR (CD2Cl2, ppm): δ 7.43–7.34 (m, 5H, 
aromatic ring), δ 6.49 (dd, J = 14.4 Hz, J = 6.9 Hz, 50H, CH2OCHCH2), 5.08 (d, J = 8.1 
Hz, 2H, POCH2Ar), 4.34–4.15 (broad, 350H, POCH2CH2OP, POCH2CH2OCHCH2 and 
CH2OCHCHH), 4.06 (broad dd, J = 6.9 Hz, J = 2.1 Hz, 50H, CH2OCHCHH), 3.94–3.86 
(broad t, 100H, POCH2CH2OCHCH2).  
13
C NMR (CD2Cl2, ppm): δ 151.9, 129.1, 128.6, 
87.7, 67.4 (d, J = 28.2 Hz), 67.2–66.6 (m).  31P NMR (CD2Cl2, ppm): δ -0.68.  DSC: (Tg) 
= -39 °C.  TGA in N2: 225 °C, 10% mass loss; 245 °C, 10% mass loss; 285 °C, 22% 
mass loss; 48% mass remaining above 285 °C.   
4.3.6. Thiol-ene “Click” Reaction of Vinyl Ether Side Chain Moieties of PEVEP50 
with 2-(2-Methoxyethoxy)ethanethiol 
A solution of PEVEP50 (0.3003 g, 0.035 mmol), 2-(2-methoxyethoxy)ethanethiol 
(0.6 mL, 0.6 g, 4 mmol), and DMPA (0.2302 g, 0.898 mmol) in 10 mL of MeOH was 
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irradiated under UV irradiation (365 nm, 6 W) for 1 h while being stirred.  The reaction 
mixture was purified by precipitated in diethyl ether twice and dialysis (MWCO 6–8 
kDa) in MeOH followed by DCM overnight.  A viscous liquid was collected after the 
removal of solvent in vacuo (0.3651 g, 68% yield).  GPC (THF): Mn = 6020 g/mol, PDI 
= 1.07.  IR: 3675–3175, 3050–2700, 1675–1600, 1456, 1356, 1273, 1197, 1094, 1020, 
970, 812 cm
-1
.  
1
H NMR (CD2Cl2, ppm): δ 7.45–7.30 (m, 5H, aromatic ring), 5.09 (d, J = 
8.1 Hz, 2H, POCH2Ar), 4.40–4.05 (broad, 300H, POCH2CH2OCH2CH2S and 
POCH2CH2OP), 3.72–3.44 (broad, 500H, 
POCH2CH2OCH2CH2SCH2CH2OCH2CH2OCH3), 3.33 (s, 150H, OCH2CH2OCH3), 
2.78–2.69 (broad q, 200H, OCH2CH2SCH2CH2O).  
13
C NMR (CD2Cl2, ppm): δ 129.1, 
128.5, 72.4, 71.5 (d, J = 18.9 Hz), 70.7, 70.1 (d, J = 27.9 Hz), 67.6, 67.0, 59.2, 32.4 (d, J 
= 25.5 Hz).  
31
P NMR (CD2Cl2, ppm): δ -0.68.  DSC: (Tg) = -64 °C.  TGA in N2: 280 °C, 
70% mass loss; 30% mass remaining above 280 °C. 
4.3.7. Acetalization of the Vinyl Ether Side Chain Moieties of PEVEP50 with 4-
Methylbenzyl Alcohol 
In a glovebox, a solution of PEVEP50 (0.1004 g, 0.010 mmol) and dried 4-
methylbenzyl alcohol (128 mg, 1.05 mmol) in 0.5 mL of DMF were placed in a flame-
dried 5 mL shell vial, and a solution of PTSA (20 mg, 0.12 mmol) in 0.5 mL of DMF 
was added into the solution.  After 5 min of stirring, the reaction was quenched by 
adding TEA (excess).  The reaction mixture was purified by dialysis (MWCO 6–8 kDa) 
in DMF followed by DCM overnight.  A viscous liquid was collected after the removal 
of solvent in vacuo (74.1 mg, 67% yield).  IR: 3700–3200, 3075–2775, 1622, 1454, 
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1430–1357, 1323, 1267, 1200, 1020, 966, 806, 750 cm-1.  1H NMR (CD2Cl2, ppm): δ 
7.44–7.32 (m, 5H, aromatic ring), 7.22 (d, J = 7.5 Hz, 18H, 
OCH2CCHCH(CHCH)CCH3), 7.14 (d, J = 7.8 Hz, 18H, OCH2CCHCH(CHCH)CCH3), 
6.49 (dd, J = 14.4 Hz, J = 6.9 Hz, 25H, CH2OCHCH2), 5.08 (d, J = 8.1 Hz, 2H, 
POCH2Ar), 4.87–4.75 (broad q, 9H, OCH(CH3)O), 4.59 and 4.45 (d, J = 11.4 Hz, 18H, 
OCH2ArCH3), 4.38–4.10 (broad, 325H, POCH2CH2OP, OPOCH2CH2O and 
CH2OCHCHH), 4.05 (broad dd, 25H, CH2OCHCHH), 3.94–3.84 (broad, 68H, 
POCH2CH2OCHCH2 and POCH2CH2OCH(CH3)O), 3.83–3.61 (b, 48H, 
OPOCH2CH2OH), 2.32 (s, 27H, OCH2ArCH3), 1.33 (d, J = 5.1 Hz, 27H, OCH(O)CH3).  
13
C NMR (CD2Cl2, ppm): δ 151.90, 137.85, 135.83, 129.52, 128.30, 99.87, 87.66, 70.58, 
68.1–67.6 (broad), 67.3 (d, J = 28.2 Hz), 67.2–66.4 (broad), 64.02 (d, J = 28.8 Hz), 
21.40, 20.05.  
31
P NMR (CD2Cl2, ppm): δ -0.68.  DSC: (Tg) = -27 °C.  TGA in N2: 225 
°C, 26% mass loss; 295 °C, 28% mass loss; 46% mass remaining above 295 °C. 
4.3.8. Thio-acetalization of Vinyl Ether Side Chain Moieties of PEVEP50 with 4-
Methylbenzyl Mercaptan 
In a glovebox, a solution of PEVEP50 (0.1005 g, 0.010 mmol) and dried 4-
methylbenzyl mercaptan (136 µL, 0.141 g, 1.02 mmol) in 0.5 mL of DMF were placed 
in a flame-dried vial, and a solution of PTSA (21 mg, 0.12 mmol) in 0.5 mL of DMF 
was added into the solution.  After 5 min of stirring, the reaction was quenched by 
adding TEA (excess).  The reaction mixture was purified by dialysis (MWCO 6–8 kDa) 
in DMF followed by DCM overnight.  A viscous liquid was collected after the removal 
of solvent in vacuo (73.6 mg, 73% yield).  IR: 3700–3200, 3045–2835, 1622, 1454, 
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1425–1350, 1323, 1265, 1200, 1020, 966, 812, 739 cm-1.  1H NMR (CD2Cl2, ppm): δ 
7.44–7.32 (m, 5H, aromatic ring), 7.20 (d, J = 8.1 Hz, 8H, SCH2CCHCH(CHCH)CCH3), 
7.11 (d, J = 7.8 Hz, 8H, SCH2CCHCH(CHCH)CCH3), 6.50 (dd, J = 14.4 Hz, J = 6.9 Hz, 
28H, CH2OCHCH2), 5.09 (d, J = 8.1 Hz, 2H, POCH2Ar), 4.71 (q, J = 6.3 Hz, 4H, 
SCH(CH3)O), 4.38–4.09 (broad, 328H, POCH2CH2OP, OPOCH2CH2O and 
CH2OCHCHH), 4.06 (broad dd, 28H, CH2OCHCHH), 3.94–3.83 (broad, 64H, 
POCH2CH2OCHCH2 and POCH2CH2OCH(CH3)S), 3.83–3.58 (broad, 62H, 
OPOCH2CH2OH and SCH2Ar), 2.31 (s, 12H, OCH2ArCH3), 1.51 (d, J = 6.3 Hz, 12H, 
OCH(O)CH3).  
13
C NMR (CD2Cl2, ppm): δ 151.91, 129.66, 129.31, 105.54, 100.33, 
87.68, 70.67, 67.4 (d, J = 28.8 Hz), 67.2–66.6 (broad), 64.42, 61.75, 32.83, 22.34, 21.34, 
19.89.  
31
P NMR (CD2Cl2, ppm): δ -0.67.  DSC: (Tg) = -31 °C.  TGA in N2: 240 °C, 22% 
mass loss; 290 °C, 22% mass loss; 56% mass remaining above 290 °C. 
4.3.9. Synthesis of Diblock Copolymer, α-Methoxy Poly(ethylene glycol)44-block-
poly(ethylene glycol vinyl ether phosphotriester)33, mPEG44-b-PEVEP33 
In a glovebox, a solution of EVEP (1.2950 g, 6.67 mmol) and mPEG44-OH (134 
mg, 0.067 mmol) in anhydrous DCM (1.3 mL) was placed in a flame-dried 5 mL shell 
vial with a magnetic stir bar.  DBU (30 µL, 31 mg, 0.20 mmol) was injected into the 
mixture solution.  After 6 min of stirring, the reaction was quenched by adding a solution 
of benzoic acid (excess).  The reaction mixture was purified by dialysis in MeOH 
followed by DCM overnight.  A viscous solid was collected after the removal of solvent 
in vacuo (0.6776 mg, 79% yield).  GPC (THF): Mn = 6550 g/mol, PDI = 1.09.  IR: 
3700–3325, 3020–2780, 1620, 1454, 1323, 1269, 1200, 1022, 972, 814, 748 cm-1.  1H 
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NMR (CD2Cl2, ppm): δ 6.49 (dd, J = 14.4 Hz, J = 6.9 Hz, 33H, CH2OCHCH2), 4.34–
4.12 (broad, 231H, POCH2CH2OP, POCH2CH2OCHCH2 and CH2OCHCHH), 4.06 
(broad dd, J = 6.9 Hz, J = 2.1 Hz, 33H, CH2OCHCHH), 3.94–3.86 (broad t, 66H, 
POCH2CH2OCHCH2), 3.61–3.58 (broad, 176H, CH3OCH2CH2O), 3.33 (s, 3H, 
CH3OCH2CH2OCH2).  
13
C NMR (CD2Cl2, ppm): δ 151.9, 87.7, 71.0, 67.4 (d, J = 28.2 
Hz), 67.2–66.6 (broad).  31P NMR (CD2Cl2, ppm): δ -0.71.  DSC: (Tg) = -38 °C. TGA in 
N2: 250 °C, 16% mass loss; 265 °C, 10% mass loss; 300 °C, 27% mass loss; 47% mass 
remaining above 300 °C. 
4.3.10. General Procedure for the Self-assembly of mPEG44-b-PEVEP33 
The amphiphilic diblock copolymer, mPEG44-b-PEVEP50, (1.0 mg) was 
suspended into nanopure water (for TEM and AFM analyses), 3-(N-
morpholino)propanesulfonic acid (MOPS) buffer (10 mM, pH 7.4) or ammonium acetate 
buffer (10 mM, pH 5.0) (for DLS and zeta potential measurements) in a vial and stirred 
at room temperature for 30 min. 
4.3.11. Investigation of the Micelle Stability in Aqueous Solution by Monitoring the 
Changes in Hydrodynamic Diameters and Intensity, Scattered by Micelles, as 
Measured by DLS 
Amphiphilic diblock copolymers, mPEG44-b-PEVEP33, were dissolved (1 
mg/mL) in 3-(N-morpholino)propanesulfonic acid (MOPS) buffer (10 mM, pH 7.4) or 
ammonium acetate buffer (10 mM, pH 5.0) in a vial.  The prepared solutions were 
stirred at room temperature or incubated in a shaker at 37 °C and, hydrodynamic 
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diameter and intensity, scattered by the micelles were monitored by using DLS over a 
period of time. 
4.3.12. Investigation of the Degradability of the PEVEP Backbone Segment in 
Aqueous Solution by Using 
31
P NMR Spectroscopy 
A solution of amphiphilic diblock copolymers, mPEG44-b-PEVEP33, (10 mg/mL) 
in 3-(N-morpholino)propanesulfonic acid (MOPS) buffer (10 mM in D2O, pH 7.4) or 
sodium acetate buffer (10 mM in D2O, pH 5.0) was incubated in a shaker at 37 °C and, 
and the backbone degradability of PEVEP was monitored by 
31
P NMR spectroscopy 
over a period of time.  
4.3.13. Investigation of the Stability of the Vinyl Ether Side Chain Moieties in 
Aqueous Solution by Using 
1
H NMR Spectroscopy 
A solution of amphiphilic diblock copolymers, mPEG44-b-PEVEP33, (10 mg/mL) 
in 3-(N-morpholino)propanesulfonic acid (MOPS) buffer (10 mM in D2O, pH 7.4) or 
sodium acetate buffer (10 mM in D2O, pH 5.0) was incubated in a shaker at 37 °C and, 
the disappearance of the vinyl group and the appearance of acetaldehyde 
1
H resonance 
peaks were monitored by using 
1
H NMR spectroscopy over a period of time.  
4.3.14. Preparation and Identification of the Degradation Products of the Micelles 
A solution of amphiphilic diblock copolymers, mPEG44-b-PEVEP33, (6 mg/mL) 
in ammonium acetate buffer (D2O, 10 mM, pH 5.0) was incubated in a shaker at 37 °C 
until the micelle detection was not possible by DLS and the complete disappearance of 
31
P resonance signal from the intact PEVEP backbone was confirmed by 
31
P NMR 
 134 
 
spectroscopy.  The solution was lyophilized into a powder, and then analyzed by ESI, 
GC and MALDI-TOF MS.   
4.3.15. Preparation of Degradation Products for Cytotoxicity Tests 
A solution of amphiphilic diblock copolymers, mPEG44-b-PEVEP33, (9 mg/mL) 
in phosphate buffered saline (PBS) (10 mM, pH 7.4) was incubated in a shaker at 37 °C 
until the micelles were not detectable by DLS.  The solution was lyophilized into a 
powder and was used for the cytotoxicity tests. 
4.3.16. Cytotoxicity Assays 
Human ovarian adenocarcinoma cells (OVCAR-3) (5 × 10
3
 cells/well) and RAW 
264.7 mouse macrophages (2 × 10
4
 cells/well) were plated in 96-well plates in RPMI-
1640 medium and Dulbecco's Modified Eagle's Medium (DMEM) (20% and 10% fetal 
bovine serum, for the OVCAR-3 and RAW 264.7, respectively, and 1% 
penicillin/streptomycin).  Cells were incubated at 37 °C in a humidified atmosphere 
containing 5% CO2 atmosphere.  The medium was replaced with a fresh medium 24 h 
after seeding, and 1 h prior to the addition of the various formulations at concentrations 
ranged from 18.0 × 10
-3
 to 1.76 µg/mL of polymer dissolved in phosphate buffered 
saline (PBS).  For each well, 20 µL of each formulation was added to 100 µL of the 
medium.  Negative controls were created by addition of 20 µL of PBS to wells 
containing 100 µL of the medium.  The cells were incubated for 24 h, and after this 
period, the media was replaced with 100 μL of the complete medium.  Then, 20 μL of 
the MTS combined reagent was added to each well (Cell Titer 96® Aqueous Non-
Radioactive Cell Proliferation Assay, Promega Co.).  The cells were incubated with the 
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reagent for 2 h for RAW 264.7 cells, and 3 h for OVCAR-3 cells, at 37 ˚C in a 
humidified atmosphere containing 5% CO2 protected from light.  Absorbance was 
measured at 490 nm by using SpectraMax M5 (Molecular Devices Co.).  The cell 
viability was calculated based on the relative absorbance to the control untreated cells. 
4.4.  Conclusions 
In conclusion, a novel polyphosphoester with ethylene glycol vinyl ether side 
chain functionality was developed as a versatile template for postpolymerization 
modifications, and its degradability and biocompatibility were investigated.  A well-
defined (PDI ≤1.05) homopolymer with vinyl ether side chain functionality was 
prepared by conducting ROP using an organocatalyst, DBU.  The kinetic study of this 
homopolymerization revealed an excellent controllability during ROP with 
predetermined molecular weights and narrow molecular weight distributions.  
Subsequently, the vinyl ether side chain moieties displayed chemical availability and 
reactivity upon conjugation with hydroxyl- or thiol-containing model small molecules 
via three different types of conjugation chemistries – thiol-ene “click” reaction, 
acetalization, or thio–acetalization reaction – resulting in modified polymers that 
contained either stable thio–ether or hydrolytically–labile acetal or thio–acetal linkages.  
Despite the relatively low conversion percentages observed during acetalization and 
thio-acetalization, ca. 18 and 8%, respectively, we anticipate that these degrees of 
conjugation efficiency would be adequate to achieve a sufficient loading of diagnostic 
and/or therapeutic molecules into this nanoparticle system.  Meanwhile, amphiphilic 
diblock copolymers, mPEG44-b-PEVEP33, were also prepared by ROP, and they afforded 
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well-defined micelles with a narrow and monomodal size distribution in water.  The 
degradation study of the prepared micelles demonstrated a full acid-catalyzed hydrolytic 
degradation behavior of both the side chain functionalities and the backbone linkages.  
Finally, the parent micelles and their degradation products, as identified qualitatively by 
mass spectrometry, were found to be nontoxic toward RAW 264.7 mouse macrophages 
and OVCAR-3 human ovarian adenocarcinoma cells.  The fundamental understanding of 
selective hydrolysis of the vinyl ether and/or acetal/thio–acetal moieties for the 
introduction of hydroxyl groups to the PPE system, which was conventionally limited to 
a cyclic PPE monomer, as a potential protecting group strategy is currently under 
investigation.  Moreover, incorporation of biologically–active molecules into these 
PEVEP-based functional, degradable polymers via the presented conjugation chemistries 
is underway. 
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CHAPTER V  
CONCLUSIONS 
 
In the development of highly well-defined polymer nanoparticles (NPs) 
demonstrating unique performance toward the effective treatment of infectious diseases, 
the combination of state-of-the-art polymerization chemistries, postpolymerization 
chemical modifications, supramolecular assembly processes and further transformations 
is essential.  Toward this aim, this research dissertation heighted two parts:  (1) 
development of potentially fully degradable, biocompatible NPs as delivery carriers for 
silver-based antimicrobials, as described in Chapter II, and (2) preparation and 
evaluation of degradable, biocompatible, and functional polymeric system as potential 
delivery carrier, as discussed in Chapter III and IV.  
In Chapter II, synthesis of a diblock copolymer, polyphosphoester-block-poly(L-
lactide) (PPE-b-PLLA), which has potential for being fully degradable and 
biocompatible, was achieved by one-pot sequential ring-opening polymerizations 
(ROPs) of two cyclic monomers:  alkyne-functionalized phospholane and L-lactide 
(LLA).  A kinetic study of the polymerization in each step was investigated in a detailed 
manner by nuclear magnetic resonance spectroscopy (NMR) and gel permeation 
chromatography, revealing living/controlled characteristics with narrow molecular 
weight distributions and a linear increase of molecular weights vs. monomer conversion 
and time.  Subsequently, photoinduced thiol-yne “click” reactions with small-molecule 
thiols bearing either carboxylic acid or amino groups afforded amphiphilic diblock 
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copolymers with carboxylate or amino side-chain functionalities along the PPE segment 
of the diblock copolymer backbone.  Finally, direct dissolution of the two different types 
of amphiphilic diblock copolymers in aqueous solutions yielded well-defined spherical 
micelles with corresponding negative or positive surface charges, respectively, as 
confirmed by transmission electron microscopy, dynamic light scattering, and zeta 
potential analyses. 
In Chapter III, silver-bearing, fully biodegradable and functional polymeric NPs 
were developed, and their antimicrobial activity was evaluated in vitro.  A series of 
degradable polymeric nanoparticles (dNPs), composed of PPE and PLLA and designed 
specifically for silver loading into the hydrophilic shell and/or the hydrophobic core, 
were prepared as potential delivery carriers for three different types of silver-based 
antimicrobials – silver acetate or one of two silver carbene complexes (SCCs).  Silver-
loading capacities of the dNPs were not influenced by the hydrophilic block chain 
length, loading site (i.e., core or shell), or type of silver compound, but optimization of 
the silver feed ratio was crucial to maximize the silver loading capacity of dNPs, up to 
ca. 12% (w/w).  The release kinetics of silver-bearing dNPs revealed 50% release at ca. 
2.5–5.5 h depending on the type of silver compound.  In addition, we undertook a 
comprehensive evaluation of the rates of hydrolytic or enzymatic degradability and 
performed structural characterization of the degradation products.  Interestingly, 
packaging of the SCCs in the dNP-based delivery system improved minimum inhibitory 
concentrations up to 70%, compared with the SCCs alone, as measured in vitro against 
10 contemporary epidemic strains of Staphylococcus aureus and eight uropathogenic 
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strains of Escherichia coli.  We conclude that these dNP-based delivery systems may be 
beneficial for direct epithelial treatment and/or prevention of ubiquitous bacterial 
infections, including those of the skin and urinary tract.  Further studies include the 
understanding of fundamental interactions between bacterial cells, the dNPs and their 
degradation products.  Moreover, conjugation of the dNPs with tissue-specific targeting 
proteins or peptides and determination of in vivo biodistribution, toxicity, and 
therapeutic efficacy of the Ag-dNPs against bacterial infectious diseases represent 
important future goals in demonstrating the translational potential of these novel 
nanoconstructs. 
In Chapter IV, a novel PPE with vinyl ether side chain functionality was 
developed as a versatile template for postpolymerization modifications, and its 
degradability and biocompatibility were evaluated.  An organocatalyzed ROP of 
ethylene glycol vinyl ether-pendant cyclic phosphotriester monomer allowed for 
construction of poly(ethylene glycol vinyl ether phosphotriester) (PEVEP).  This vinyl 
ether-functionalized PPE scaffold was coupled with hydroxyl- or thiol-containing model 
small molecules via three different types of conjugation chemistries – thiol–ene “click” 
reaction, acetalization, or thio–acetalization reaction – to afford modified polymers that 
accommodated either stable thio-ether or hydrolytically-labile acetal or thio-acetal 
linkages.  Amphiphilic diblock copolymers of poly(ethylene glycol) and PEVEP formed 
well-defined micelles with a narrow and monomodal size distribution in water, as 
confirmed by DLS, transmission electron microscopy, and atomic force microscopy.  
The stability of the micelles and the hydrolytic degradability of the backbone and side 
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chains of the PEVEP block segment were assessed by DLS and NMR spectroscopy (
1
H 
and 
31
P), respectively, in aqueous buffer solutions at pH values of 5.0 and 7.4 and at 
temperatures of 25 and 37 °C.  The hydrolytic degradation products of the PEVEP 
segments of the block copolymers were then identified by electrospray ionization, gas 
chromatography, and matrix-assisted laser desorption/ionization mass spectrometry.  
The parent micelles and their degradation products were found to be non-cytotoxic at 
concentrations up to 3 mg/mL, when evaluated with RAW 264.7 mouse macrophages 
and OVCAR-3 human ovarian adenocarcinoma cells.  The fundamental understanding of 
selective hydrolysis of the vinyl ether and/or acetal/thio–acetal moieties for the 
introduction of hydroxyl groups to the PPE system, which was conventionally limited to 
a cyclic PPE monomer, as a potential protecting group strategy would be vital.  
Moreover, the future studies include incorporation of biologically–active molecules into 
these PEVEP-based functional, degradable polymers via the presented conjugation 
chemistries. 
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